Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2018

The Influence of Clinically Meaningful Factors on the
Performance of the Recommended Annual Diabetic Foot
Screening
Trisha A. Sando
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Clinical Epidemiology Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/5323

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

© Trisha A. Sando, DPT, CWS, MSc
All Rights Reserved

1

2018

The Influence of Clinically Meaningful Factors on the Performance of the
Recommended Annual Diabetic Foot Screening

A dissertation submitted in partial fulfillment of the requirements for the degrees of Doctor of
Philosophy at Virginia Commonwealth University

By:
Trisha Arlene Sando, Ph.D, DPT, CWS, MSc
Bachelors of Science in Biology, California Institute of Technology, 2001
Doctor of Physical Therapy, University of Southern California, 2005
Masters of Science in Wound Healing and Tissue Repair, Cardiff University, 2015

Director:
Juan Lu, Ph.D., MPH, MD
Associate Professor
Division of Epidemiology, Department of Family Medicine and Population Health
Virginia Commonwealth University

Virginia Commonwealth University
Richmond, Virginia
April, 2018

i

Acknowledgements

The author wishes to thank several people for their support throughout the writing of this
dissertation process. I would like to thank the members of my dissertation committee: Dr. Juan
Lu, Dr. Steven A. Cohen, Dr. Robert Perera and Dr. Edmond Trey Wickham for their guidance
throughout this project. I would like to thank the Department of Family Medicine and
Population Health, Division of Epidemiology for their support. Thank you also to Dr. Daniel
Provenzano who assisted in generating the figures present in Chapters 4 and 5 of this
dissertation. I would like to thank my parents, Mr. Stewart Sando and Mrs. Patricia Sando, my
sisters Mrs. Renee Pearl and Mrs. Rebecca Gunning for all of their support during my many
academic pursuits including the writing of this dissertation project.

ii

Table of Contents

List of Tables and Figures…………………………………………………………………………v
List of Abbreviations……………………………………………………………………………..vi
Abstract……………………………………………………………………………………………1
CHAPTER 1: Background………………………………………………………………………...3
CHAPTER 2: Description of the dataset………………………………………………………...14
CHAPTER 3: Are diabetes mellitus self-care behaviors associated with the receipt
of the recommended annual diabetes foot screening examination?...............................................17
Abstract…………………………………………………………………………………..18
Introduction………………………………………………………………………………20
Research design and methods……………………………………………………………21
Results……………………………………………………………………………………26
Conclusions………………………………………………………………………………34
CHAPTER 4: The association between comorbidities and the performance
of the recommended annual diabetes foot screening examination………………………………38
Abstract…………………………………………………………………………………..39
Introduction………………………………………………………………………………40
Research design and methods……………………………………………………………43

iii

Results……………………………………………………………………………………48
Conclusions………………………………………………………………………………54
CHAPTER 5: The association between visit frequency and competing demands on the
performance of the recommended annual clinical diabetic foot screening………………………59
Abstract…………………………………………………………………………………..60
Introduction………………………………………………………………………………61
Research design and methods……………………………………………………………62
Results……………………………………………………………………………………66
Conclusions………………………………………………………………………………72
CHAPTER 6: Summary………………………………………………………………………….76
CHAPTER 7: References………………………………………………………………………..84
Vita……………………………………………………………………………………………….94

iv

List of Tables and Figures

Table 1-1. Recommended diabetes self-management behaviors and reported
rates of adherence………………………………………………………………………..10
Table 3-1. Characteristics of persons aged >18 years with diagnosed diabetes,
38 states (n=14,823)……………………………………………………………………...27
Table 3-2. Reported performance of recommended diabetes mellitus
self-management behaviors in persons aged ≥18 years with diagnosed
diabetes, 38 states (n=14,823)……………………………………………………………30
Table 3-3. Multiple Logistic Regression Model Estimates of Odds Ratios
(OR) and 95% CI for the association between patient performance
of 8 individual diabetes mellitus self-care behaviors on the
performance of the recommended annual diabetes foot screening
examination (n=14,823)………………………………………………………………….32
Table 3-4. Multiple logistic regression model estimates of odds ratios
(OR) and 95% CI to assess for outcome non-response bias in
estimates for the influence of patient performance of 8 individual
diabetes mellitus self-management behaviors on the performance
of the recommended annual diabetes foot screening examination………………………34
Table 4-1. Recommended diabetes preventive care processes and
Healthy People 2020 reported results……………………………………………………41
Table 4-2. Demographic characteristics of persons aged ≥18 years with
diagnosed diabetes, 38 states (n=20,882)………………………………………………..49
Table 4-3. Reported comorbid conditions in persons aged ≥18 years with
diagnosed diabetes, 38 states (n=20,882)………………………………………………..51
Table 4-4. Unstandardized coefficients, standardized coefficients and
percentage of variance explained for the final CFA model……………………………...53
Figure 4-1. Final SEM model…………………………………………………………………...54
Table 4-5. Unstandardized estimates (β), standard error (SE) and p-values
for regression pathways of the final SEM model………………………………………...54
Table 5-1. Demographic characteristics of persons aged ≥18 years with
diagnosed diabetes, 38 states (n=19,056)………………………………………………..67
Table 5-2. Reported completion of diabetes preventive care processes in
persons aged ≥18 years with diagnosed diabetes, 38 states (n=19,056)…………………69
Table 5-3. Final CFA model unstandardized coefficients, standardized
coefficients and percentage of variance explained for each indicator…………………...71
Figure 5-1. Final SEM model…………………………………………………………………...71
v

Table 5-4. Odds ratios (OR), 95% confidence intervals (95% CI)) and
p-values for regression pathways of the final SEM model………………………………72

vi

List of Abbreviations

ADA- American Diabetes Association
ADFSE- annual diabetes foot screening examination
BRFSS- Behavioral Risk Factor Surveillance System
CAD- coronary artery disease
CDC- Centers for Disease Control and Prevention
CFA- confirmatory factor analysis
CFI- comparative fit index
CMS- Centers for Medicare and Medicaid Services
COPD- Chronic obstructive pulmonary disease
CVA- cerebrovascular accident
DFU- diabetic foot ulcer
EMR- electronic medical record
HgbA1c- glycosylated hemoglobin/hemoglobin A1c
IWGDF- International Working Group on the Diabetic Foot
LEA- lower extremity amputation
MEPS- Medical Expenditures Panel Survey
MI- myocardial infarction
PCMH- patient centered medical home
PN- peripheral neuropathy
PQRI- Physicians Quality Reporting Initiative
PQRS- Physicians Quality Reporting System
PVD- peripheral vascular disease
RMSEA- root mean squared error of approximation
SEM- structural equation modeling
SMBG- self-monitoring blood glucose
T1DM- type 1 diabetes mellitus
T2DM- type 2 diabetes mellitus
VHA- Veterans Health Administration

vii

Abstract

THE INFLUENCE OF CLINICALLY MEANINGFUL FACTORS ON THE
PERFORMANCE OF THE RECOMMENDED ANNUAL DIABETIC FOOT
SCREENING
By: Trisha Arlene Sando, DPT, CWS, MSc, Ph.D.

A dissertation submitted in partial fulfillment of the requirements for the degrees of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2018

Director:
Juan Lu, Ph.D., MPH, MD
Associate Professor
Division of Epidemiology, Department of Family Medicine and Population Health
Virginia Commonwealth University

Background: Diabetic foot ulcers are the result of multiple complications from hyperglycemia
and lead to poor quality of life and high healthcare costs. The annual diabetes foot screening
exam (ADFSE) and prevention interventions can reduce DFUs up to 75%. In 2015, 71% of the
US population received the ADFSE.
Objectives: The main objectives of this dissertation were: 1) to determine the association
between adherence to diabetes self-management behaviors and the ADFSE, 2) to determine the
association between concordant and discordant comorbidities and the ADFSE and 3) to
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determine the association between the performance of diabetes preventive care processes,
number of office visits for diabetes and the completion of the ADFSE.
Methods: Three cross-sectional studies used data from the 2015 Behavioral Risk Factor
Surveillance System. Logistic regression models were evaluated to assess the association
between the self-management behaviors and the ADFSE. Structural equation modeling (SEM)
was used to assess the simultaneous, direct effects of concordant and discordant comorbidity
loads on the ADFSE and the performance of diabetes preventive care processes and the number
of office visits for diabetes care on the ADFSE.
Results: In 2015, between 78.2% and 80.4% of the US population with diabetes received the
ADFSE. Performance of the ADFSE was 77% less likely (OR: 0.33, 95%CI: 0.25-0.44) in
those who do not perform self-foot inspections and 40% (OR: 0.59, 95%CI: 0.45-0.76) less
likely in those who have never received the pneumococcal vaccination. Receiving the ADFSE
was 50-80% less likely in patients who do not self-monitor blood glucose at least one time per
day, depending on insulin use and receipt of diabetes education. Neither concordant
comorbidities (β=0.226, p=0.086) nor discordant comorbidities (β=0.080, p=0.415) had a direct
association with the performance of the ADFSE. The collection of preventive care processes
demonstrated a 7% (OR: 1.07, 95% CI: 1.05-1.10) increase in the likelihood the ADFSE was
performed
Conclusions: Performance of the ADFSE may be improved through multiple types of
interventions. Patient-based interventions to increase adherence to self-management behaviors is
one route. Programs to improve overall diabetes care in the clinical setting may also help to
further improve completion of the ADFSE.
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CHAPTER 1: Background
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BACKGROUND
Physiology and Epidemiology of Diabetes Mellitus
According to the estimates by the US Centers for Disease Control and Prevention (CDC)
and the National Center for Health Statistics, it is estimated that over 30 million people, over the
age of 18, are currently living with diabetes in the US (1). Nine percent of US residents have
been diagnosed diabetes mellitus but nearly 3.0% of the US population remain undiagnosed (2).
The prevalence is expected to increase to 21-33% by 2050 (3). Diabetes is a metabolic disease
that affects the body’s ability to produce or use insulin. Type 1 diabetes mellitus (T1DM) is
characterized by the destruction of pancreatic β-cells and an absolute insulin deficiency, affects
5-10% of the population (4). Seventy-five percent of TIDM cases occur in children and
adolescents (5). Type 2 diabetes mellitus (T2DM) is characterized by the combination of insulin
resistance in tissues and dysfunctional insulin secretion. T2DM is the cause of 90-95% of cases
of diabetes. Both patient populations could experience periods of hyperglycemia, or plasma
blood glucose ≥200 mg/dL, which leads to complications. Some of the common complications
of diabetes are neuropathy, nephropathy, retinopathy and heart disease (6). These complications
are the leading causes of blindness, renal failure and non-traumatic amputations in the US (7).
As a consequence of these complications, diabetes remains the 7th leading cause of death in the
United States and resulted in almost 80,000 deaths in 2015 (2). The total cost of care for
diabetes is estimated to be over $245 billion, which is more than 2.3 times higher than care for
those without diabetes (8). Given the expected increase in prevalence, the high mortality rate
and high cost of the disease, it is imperative to focus on prevention of diabetes and its
complications.
Much of the healthcare costs for diabetes is due to the complications. Neurologic
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complications include peripheral neuropathy (PN), the loss of sensation beginning in the feet and
hands, which can affect 29-60.8% of the diabetes population (9, 10). Peripheral vascular disease
(PVD) and cardiovascular disease (CVD) rates are higher in the diabetes population due to the
acceleration of atherosclerosis and thrombus formation (6, 11). About 10% and 32% of people
with diabetes report PVD and CVD, respectively (9, 12). Retinopathy affects up to 62% of the
US diabetes while almost 37% have some degree of chronic nephropathy (8, 10). Finally, the
combination of PN and PVD can lead to diabetic foot ulcers (DFU) and lower extremity
amputations (LEA).
More than one-quarter of the national spending on neurological, peripheral vascular,
cardiovascular and renal conditions are attributed to those with diabetes (13). In 2014, rates of
hospitalization per 1,000 persons with diabetes were 18.3 for ischemic heart disease, 11.5 for
cerebrovascular accident (CVA) and 5.0 for LEA (8). In addition to hospitalization, more than
14 million people with diabetes visited the emergency department for some type of care. These
emergent visits contributed to the average individual annual health care expenditure of $13,700
(8). DFUs and LEAs, the result of neuropathy, PVD and CVD, are the leading causes of
hospitalization and cost the US health care system more than $9 billion (14, 15).

The Diabetic Foot
One major complications of diabetes occurs in the foot and is due to the pathophysiology
of hyperglycemia. Chronic hyperglycemia leads to both microvascular (PN, retinopathy, and
nephropathy) and the macrovascular (CVD, PVD) damage to tissues (16-18). In addition, the
immune system response is blunted leading to poor wound healing and increased risk of wound
infection (7). The development of the diabetic foot usually begins with PN. Diabetic PN affects
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the sensory, motor and autonomic branches of the peripheral nervous system (19). Sensory
neuropathy results in the loss of ability to detect light touch, vibration, temperature and pain (20).
In diabetes, sensory neuropathy typically bilateral and begins in the toes and then moves
proximally as the disease progresses. As a result, individuals with sensory neuropathy are unable
to detect minor trauma. The nerves innervating the intrinsic muscles of the foot are also
damaged by hyperglycemia and result in motor neuropathy. The resulting muscle weakness
leads to skeletal deformities such as hammer toes, claw toes and an unstable arch, which, in turn,
creates areas of excessive pressure which are prone to tissue injury (7, 19). Finally, autonomic
neuropathy leads to impaired blood flow regulation as well as anhidrosis and dry skin that is
prone to cracking and fissuring (19). These conditions place the foot at risk for invasion by
bacteria and fungus and ultimately wound development.

Diabetic Foot Ulcers
Any injury to the diabetes foot can progress into a DFU. A DFU results from a break in
the skin, into or beyond the dermis, which fails to heal in a timely fashion (7, 21). The most
common causal pathway for the development of a DFU is through the combination of sensory
neuropathy, foot deformities from motor neuropathy and minor traumatic events to the feet (22).
An international clinical study found that among patients with a prior DFU nearly 80% had
sensory neuropathy, 63% had a foot deformity and 77% reported minor trauma that incited the
DFU. Other components of the DFU causal pathway may include: PVD, impaired capillary
blood flow, the presence of calluses, and edema. Due to impaired immune system function and
the high prevalence of decreased blood flow in the diabetes population, DFUs are difficulty to
heal and prone to infection.
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The lifetime risk of developing a DFU can be as high as 34% in the diabetes population
(23). The incidence of DFU is estimated between 1.9-4.1% annually and if healed, the
recurrence rate is as high as 70% (24). Amongst the Medicare population, the incidence rate is
higher, at 6.0%, with an annual prevalence of 8.0% (25, 26). The management of DFUs costs
the US healthcare system between $9 and $13 billion annually with 77% of the cost is due to
inpatient hospital admissions (15, 24).

Lower Extremity Amputation
When medical treatment fails, LEA, the most severe lower extremity consequence of
diabetes, is the only option (24). LEAs occur 15 times more often in those with diabetes than in
those who do not have diabetes, and 85% of all diabetes LEAs are preceded by a DFU (21). At
least 5.0 LEAs per 1,000 persons with diabetes were performed in the US in 2014 (8). LEAs in
the Medicare population increase average annual reimbursement to over $54,000 (27).
Perhaps the greatest cost of DFUs and LEAs is mortality. The 5-year mortality rates for
diabetes patients is 45-55% and 47% for those with a DFU and LEA, respectively (28). These
mortality rates are higher than most cancers, and only pancreatic and lung cancers are more
deadly (29). On the contrary, prevention strategies to reduce DFUs and LEAs only cost 10% of
the total treatment costs for the conditions, making prevention an ideal target to address this large
public health problem (29, 30).
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Diabetic Foot Ulcer Prevention and the Recommended Annual Diabetes Mellitus Foot
Screening Examination
Evidence has shown that up to 75% of DFUs and 49-85% of LEAs, were preventable
through cost effective screening and prevention programs (31, 32). All prevention programs
begin with foot screening exam to determine the risk of developing a DFU. The American
Diabetes Association (ADA) and the International Working Group on the Diabetic Foot
(IWGDF) recommend an annual diabetes foot screening examination (ADFSE) be performed at
least once per year on all patients with diabetes over the age of 18 (33-35). Patients with
abnormal screenings should have a foot examination on every visit to a health care professional
(33, 36).
The ADFSE should include: patient history, general visual foot inspection for
dermatologic problems, and musculoskeletal, neurologic and vascular examinations. All
portions of the ADFSE can be performed by a variety of health care providers including
physicians, nurses, physical therapists and pharmacists, requires minimal specialty equipment
and can be performed in less than 5 minutes (37). Despite these national estimates indicate only
71% of the US population received the ADFSE in 2012 (38). Clinical reports of ADFSE
completion vary from 12% to 95% adherence (39-46). Prior research has identified race, gender,
age, education, insurance and rural residency as factors that influence the performance of the
ADFSE (47-49). However, other clinically meaningful patient level factors, such as diabetes
self- management behaviors adherence, the influence of comorbidities and factors related to
clinical care are still not well understood. Some of these clinically meaningful patient level
factors can be explored using a conceptual framework on competing demands presented by
Piette and Kerr (50).
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Conceptual Model- Piette and Kerr Framework for Competing Demands
The Piette and Kerr framework for competing demands on diabetes care demonstrates
that diabetes specific care and health are influenced directly by diabetes self-management
behaviors, diabetes medical management as well as comorbidity self-management behaviors and
medical management. Further it suggests that these care processes are not only influenced by
patients’ and clinicians’ priorities and resources but also by healthcare organizations. This
framework has been utilized in prior research to explore how patient level and clinical factors
have influenced the care of patients with diabetes (51-55). This dissertation explored the direct
relationships between performance of the ADFSE and three of the major pathways of the Piette
and Kerr conceptual model.
Aim 1. To determine whether patient performance of 8 individual diabetes mellitus selfmanagement behaviors are associated with clinicians’ decisions to perform the ADFSE.
Aim 2. To assess the simultaneous, direct effects of concordant and discordant comorbidities on
the performance of the annual diabetes foot screening exam (ADFSE), using structural equation
modeling (SEM), to simulate clinical decision making.
Aim 3. To examine the relationship between the performance of other diabetes preventive care
processes, number of office visits for diabetes services and the completion of the recommend
ADFSE.
Based on knowledge generated by these studies, clinicians and policy makers will be
provided with more information on how to improve the performance of the ADFSE. Improved
screening of the diabetes foot will lead to early recognition and better management of diabetic
foot problems, and ultimately reduce the major health and economic burdens for patients with
diabetes and our society at large.
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Diabetes Self-management Behaviors and the ADFSE
Patient participation in the management of diabetes is imperative to achieving good
outcomes and preventing complications and is, thus, strongly supported by the ADA and other
national and international organizations (56-58). The recommended self-management behaviors
and reported rates of patient adherence are listed in Table 1-1. Adherence to these selfmanagement behaviors can result in improved hemoglobin A1c (HgbA1c) control, reduced
visceral adipose tissue and plasma triglycerides which, in turn, can reduce the risks of
comorbidities and complications associated with diabetes, including DFU and LEA (59, 60). In
the conceptual model by Piette and Kerr, diabetes self-management behaviors are characterized
as important factors that could directly influence diabetes health care, including performance of
the ADFSE (50).
Table 1-1 - Recommended diabetes self-management
behaviors and reported rates of adherence (56, 57, 6164)
Diabetes self-management
Reported rate of
behavior
adherence
Self-monitoring blood glucose
42-64%
Healthy eating/Diet modification
50-81%
No smoking
75%
Self-foot care
20-60%
Being physical active
50-78%
Receive influenza vaccination
50%
Receive pneumococcal
43%
vaccination

A cross-sectional study among patients with T1DM in Pittsburg, Pennsylvania found no
association between performing self-monitoring of blood glucose (SMBG) at least once per week
and changing insulin dosing based on blood glucose levels (42). However, those who performed
SMBG at least once per day had an almost 2-fold increasing odds of receiving the ADFSE (41).
10

A cross-sectional study among Asian-Americans found no association between tobacco usage
and alcohol consumption and the performance of the ADFSE (65). The heterogeneity of the
study samples, self-management behaviors and preventive care behaviors studied limits
comparability and generalizability to the US population. Thus this dissertation aimed to
determine the association between patient adherence to diabetes self-management ADFSE using
nationally representative data.

Comorbidities and the ADFSE
The medical management of patient with diabetes is complicated by the presence of other
comorbidities and quality of diabetes care must be viewed in this light. Diabetes care comes
with a collection of recommended preventive care processes, including the ADFSE. All these
processes must be completed in the limited time available during an office visit along with the
preventive care processes for other comorbidities. In clinical practice, the number of
recommended preventive care processes varies based on each patient’s comorbidities.
National estimates showed that amongst those with diabetes in the US, nearly 85% were
overweight or obese, 57% had hypertension and over 58% had hypercholesterolemia (66). In
those aged over 35, coronary artery disease (CAD) and myocardial infarctions (MI) affect nearly
22% of those with diabetes, while over 9% have suffered a CVA (67). Nearly 10 years ago, 90%
of the US diabetes population had at least one other comorbidity and more than a quarter had 5
or more (68). Given these high rates of comorbidities and multiple concurrent comorbidities, it
is imperative to understand how they affect diabetes quality of care, in particular, the ADFSE.
The association between comorbidities and diabetes preventive care processes has been
explored in multiple studies by operationalizing comorbidities as a total count, individual
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comorbidities or classified as concordant or discordant with diabetes care processes (52, 54, 55,
68-71). Thus far, the literature has suggested that comorbidity counts, individual comorbidities,
and types of comorbidities may all exert an influence on the performance of diabetes preventive
care processes. However, no studies in the US have investigated the relationship between
comorbidities and the ADFSE. Two international studies found no significant relationship
between comorbidities classified as concordant or discordant with diabetes care and the
performance of the ADFSE (72, 73). Given the paucity of research regarding the association
between comorbidities and the performance of the ADFSE, this dissertation sought to explore
these relationships.

Visit Frequency, Competing Demands and the ADFSE
The final pathway of the Piette and Kerr model explored in this dissertation was the
association between “Diabetes Medical Management” and overall diabetes care (50). Diabetes
medical management can include the provision of preventive care processes, diabetes medication
management, management of concurrent comorbidities, patient behavior counseling and other
competing demands (45, 74-76). Health care providers are faced with the need to prioritize
delivery of preventive care processes during each patient visit which contributes to the observed
suboptimal rates of preventive care delivery (74, 77, 78). Further understanding of the influence
of these competing demands is necessary to improve the rates of preventive care delivery,
including the ADFSE for patients with diabetes.
No available research has explored the influence of clinical competing demands on
diabetes care. However, a study utilizing cross-sectional data from Michigan investigated the
influence of diabetes preventive care processes on the performance of mammograms and Pap
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smears in female patients with diabetes (79). Both the performance of mammograms and Pap
smears increased significantly as the number of completed diabetes care processes increased.
While the individual diabetes care processes were not investigated, this study demonstrated
improved diabetes preventive care positively influences other preventive health care processes in
the female population. It is possible that completion of other diabetes preventive care processes
may help improve rates of completion of the ADFSE. Unfortunately, no published research has
directly explored this association.
Multiple cross-sectional studies have investigated the influence of the number of visits to
a health provider on the performance of diabetes preventive care processes. Three studies found
a positive association between patients having 4 to 8 office visits and the performance of
HgbA1c testing (65, 68, 80). Looking specifically at the performance of the ADFSE, positive
associations between number of visits to a health care provider and the ADFSE were found in
populations of patients with T1DM, Asian-Americans with diabetes and among participants in
the Medical Expenditures Panel Survey (MEPS) (41, 65, 68). Overall, no studies have addressed
the influence of both clinical competing demands and the patient visits frequency on the
performance of ADFSE.
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CHAPTER 2: Description of the dataset
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THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM
To address the proposed aims, this dissertation used data from the 2015 Behavioral Risk
Factor Surveillance System (BRFSS). The BRFSS is a cross-sectional, annual survey
administered by the CDC and conducted via land-line and cellular telephones (81). The BRFSS
interviews non-institutionalized US residents, over the age of 18 years. The system is designed
to collect information on preventive health care practices, health risk behaviors, chronic diseases,
injuries and preventable infectious diseases that affect the US adult population. Data is collected
by each state’s health department, using computer aided telephone interviewing, to provide statespecific information. Data is then compiled into a national database by the CDC. The methods
for sample weighting to account for the complex sample design are described elsewhere (82).
For this study, the BRFSS sample weighting was utilized to determine nationally representative
estimates.
The BRFSS utilizes a disproportionate stratified sample study design to collect the
landline samples (81). Since 2008, sampling frames for cellular telephones are obtained from the
Telecordia database. The BRFSS questionnaire is comprised of a core component, conducted in
every state, and optional modules on specific topics, including diabetes (81). The core
component gathers demographic information, health conditions and health behaviors. Each state
then determines which optional modules to conduct. The states participating in each optional
module are available online (83).
An optional module, asking 10 questions specific to diabetes care is available in the 2015
BRFSS dataset. In 2015, 38 states participated in the diabetes optional module (83). All survey
respondents who responded “yes” to the question “Has a doctor, nurse or other health
professional every told you that you have diabetes?” in the core component were included in the
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sample eligible to participate in the diabetes optional module. Respondents indicating the
diagnosis of gestational, borderline or pre-diabetes were excluded from the diabetes Module.
The diabetes module includes questions about diabetes specific self-management activities and
recommended preventive care processes. However, the module did not include information on
use of oral medications to manage diabetes. While the module did ask respondents if they used
insulin, it did not include information type of insulin use (basal rate vs. basal rate and bolus). A
total of 38,224 BRFSS participants were eligible to participate in the optional diabetes module.

16

CHAPTER 3: Are Diabetes Mellitus Self-management Behaviors Associated with the
Receipt of the Recommended Annual Diabetes Foot Screening Examination?
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ABSTRACT
Objective: To determine whether patient performance of 8 individual diabetes mellitus selfmanagement behaviors are associated with clinicians’ decisions to perform the annual diabetes
foot screening exam (ADFSE).
Research Design and Methods: We utilized the 2015 BRFSS data from 38 states (n=14,825) to
conduct a cross-section study. Respondents who provided a valid responses for the ADFSE and
had at least one visit to a healthcare providers in the past 12 months were included. Eight
separate multivariable logistic regression models were evaluated to assess the association
between the self-management behaviors and the performance of the ADFSE.
Results: Among adults with diabetes mellitus and at least one visit to a health provider, 78.3%
received an ADFSE. The most commonly performed self-management behaviors were
performance self-monitoring of blood glucose (SMBG) and self-foot inspections, both at least
one time per day. After controlling for covariates, performance of the ADFSE was 77% less
likely (OR: 0.33, 95%CI: 0.25-0.44) in those who do not perform self-foot inspections and 40%
less likely (OR: 0.59, 95%CI: 0.45-0.76) in those who have never received the pneumococcal
vaccination. Patients who do not perform SMBG and do not use insulin or have not had formal
diabetes education are 48% less likely (OR: 0.52, 95%CI: 0.38-0.82, OR: 0.52, 95%CI: 0.360.74, respectively) to receive the ADFSE. Finally, those who do not practice SMBG and did
receive diabetes education are 81% less likely (OR: 0.19, 95%CI: 0.09-0.94) to receive the
ADFSE.
Conclusions: Some diabetes mellitus self-management behaviors are associated with the
performance of the ADFSE. Future exploration of the casual relationship between diabetes
mellitus self-management behaviors and the resultant effects on the performance ADFSE will
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provide further information on potential intervention that can increase the performance of this
potentially life-saving screening exam.
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INTRODUCTION
The lifetime risk of developing a diabetic DFU can be as high as 34% (23). In 2010,
more than 77,000 people were hospitalized with an infected DFU and 17% of cases resulted in
an LEA (84). The management of DFUs costs the US healthcare system more than $9-13 billion
per year, in addition to the baseline cost of the care for diabetes mellitus (15). Despite advances
in wound care, more than 60% of DFUs remain unhealed after 20 weeks of standard wound care
(85). The 5-year mortality rate for the population with a DFU or LEA resulting from a DFU is
between 29% and 50% (28, 86).
Evidence has shown that up to 75% of DFUs and 49-85% of LEAs were preventable
through cost effective screening and prevention programs (31, 32). Primary prevention of DFUs
in the general US population with diabetes can be effective and cost-saving, however, in 2015
only 71.6% of the US population with diabetes received an ADFSE (87, 88). While the rates of
ADFSE performance, based on national surveys, have increased from 64.6% in 2002 to 71.6% in
2015, more than 8.6 million US residents with diagnosed diabetes did not received the ADFSE in
2015 (1, 89). Given the ADFSE is both cost-saving for the US health system and the first step in
prevention efforts, it is imperative to identify populations at risk of not being screened and
promote effective interventions to increase ADFSE rates (87).
A conceptual model to describe competing demands for diabetes care, developed by
Piette and Kerr, describes diabetes self-management behaviors as an important factor that could
directly influence the provision of diabetes-specific care, including the ADFSE (50). While
previous studies have utilized this framework to explore how patient level and clinical factors
influence the care of patients with diabetes, none have explored the role of self-management
behaviors on the performance of the ADFSE (51, 52, 54, 55).

20

Prior studies have found the performance of some diabetes self-management behaviors
have positive associations with the performance of diabetes specific screening procedures, such
as fasting lipid profiles, urine protein analysis and HgbA1c testing (41, 42, 65). Other studies
specifically examined the performance of the ADFSE. Among a small sample of individuals
with T1DM, weekly SMBG did not influence the performance of the ADFSE nor other screening
procedures. However, when SMBG was performed at least once daily in this study population,
the odds of patients receiving the ADFSE nearly doubled (41). A study among a nationally
representative sample of Asian-Americans with diabetes mellitus found no relationships between
tobacco usage and alcohol consumption and the performance of the ADFSE (65).
Overall the literature on the association between diabetes self-management behaviors and
the performance of the ADFSE is limited. The heterogeneity of the study samples, selfmanagement behaviors and preventive care behaviors studied limit comparability and
generalizability. Thus, the objective of the current study was to determine whether patient
completion of 8 individual diabetes mellitus self-management behaviors are associated with
clinicians’ decision to perform the ADFSE.

RESEARCH DESIGN AND METHODS
Data Source and Sample
This was a cross-section study using data from the 2015 BRFSS. The BRFSS is designed
to collect information on preventive health care practices, health risk behaviors, chronic diseases,
injuries and preventable infectious diseases among non-institutionalized US residents, over the
age of 18 years (81). The methods for sample weighting to account for the complex sample
design are described elsewhere (82).
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An optional module, asking 10 questions specific to diabetes care was available in the
2015 BRFSS dataset (90). In 2015, 38 states participated in the Diabetes Mellitus Optional
Module (Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida,
Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan,
Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York,
North Carolina, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas,
Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming) (83). The Diabetes Mellitus
Optional Module includes questions about diabetes mellitus specific self-management activities
and recommended preventive care processes, including the ADFSE. All survey respondents who
responded “yes” to the question “Has a doctor, nurse or other health professional every told you
that you have diabetes?” in the core component were included in the sample eligible to
participate in the Diabetes Mellitus Optional Module. Respondents indicating the diagnosis of
gestational, borderline or pre-diabetes mellitus were excluded from the Diabetes Mellitus
Optional Module in the BRFSS survey design. A total of 36,085 of the 2015 BRFSS participants
were eligible to participate in the Diabetes Mellitus Optional Module.
To be included in the study sample respondents must have a valid response to the study
outcome question, at least one foot and had at least one visit to a health provider for diabetes
mellitus care in the past year. One thousand, nine hundred and sixty-five respondents did not
provide a valid response to the outcome question and were thus excluded from the study. The
BRFSS question “About how often do you check your feet for any sores or irritations?” was used
to identify respondents without feet. Three-hundred and forty-nine individuals gave the response
of “no feet” were excluded from the analytic sample. Having at least one visit to a health
provider for diabetes mellitus care in the past year was determined utilizing the question “About
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how many times in the past 12 months have you seen a doctor, nurse or other health professional
for your diabetes?” The responses were dichotomized to “yes- at least one visit” or “no, no
visits.” Respondents who had no visits to a health provider or did not provide a valid response
were excluded from the study sample (n=3,656). BRFSS respondents who did not provide a
valid response for all exposure, covariate and confounding variables were also excluded
(n=15,292). After all exclusions were considered, the total sample size for this study was
14,823.

Measures
The primary outcome of this study was defined as having at least one ADFSE in the past
year. The study outcome variable was created from the question “About how many times in the
past 12 months has a health professional checked your feet for any sores or irritations?”
Continuous numerical responses were dichotomized to “yes, at least one time” or “no.” The
main exposures of interest for this study were self-management behaviors for people with
diabetes mellitus that were included in the 2015 BRFSS questionnaire. These behaviors included
SMBG, performance of daily self-foot inspections, annual receipt of the influenza vaccine,
receipt of a pneumococcal vaccine at any time, meeting aerobic and resistance exercise
recommendations, smoking status, and alcohol consumption.
The 2015 BRFSS Diabetes Module asked respondents “About how often do you check
your blood for glucose or sugar?” Responses were given as continuous number of times per day,
week, month or year. Based on the goal for Healthy People 2020 the variable was dichotomize
to “yes, at least one time per day” and “no, less than one time per day” (91). The International
Working Group for the Diabetic Foot recommends people with diabetes mellitus , or their
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caregiver, visually inspect their feet for changes on a daily basis (36). Thus the original,
continuous responses to the question “About how often do you check your feet for any sores or
irritations?” was dichotomized to “yes, at least one time per day” and “no, less than one time per
day.” For the receipt of the influenza vaccine in the past 12 months, the question “During the
past 12 months, have you had either a flu shot or a flu vaccine that was sprayed in your nose?”
was utilized. Receipt of the pneumonia vaccine was determined by the question “Have you ever
had a pneumonia shot?” For both vaccination questions the original responses to the questions
were either “yes received vaccine” or “no did not receive vaccination.” Based on ADA
recommendations, the 2015 BRFSS used data collected from multiple questions to calculate a
variable to indicate if a respondent “participated in 150 minutes (or vigorous equivalent of
minutes) of physical activity per week” (56). These responses were categorized by BRFSS as
“yes, performed 150+ minutes of physical activity per week” and “no, did not perform 150
minutes of physical activity per week.” The ADA also recommends performance of resistance
exercise training 2 days per week (56). The 2015 BRFSS contains the question “During the past
month, how many times per week or per month did you do physical activities or exercises to
strengthen your muscles?” was used. Responses are given as the number of days per week or
month. This study dichotomized responses to “met recommendation” and “did not meet
recommendations.” The BRFSS contains a calculated variable to indicate if a respondent was a
current smoker or not and this was utilized without change (90). Finally, the ADA recommends
that males with diabetes mellitus drink no more than 2 alcoholic beverages per day and women
no more than one per day (56). The 2015 BRFSS contains a variable that indicates whether a
male had more than 14 drinks per week and a women had more than 7 drinks per week and this
was used to define a variable for excessive alcohol usage (yes/no) (90).
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To increase comparability with existing literature this study utilized covariates similar to
variables utilized in prior research (41, 65, 92, 93). These included sex, age, race, education,
marital status, annual household income and insurance status. Potential confounders included
the number of visits to a health provider for diabetes mellitus care, number of years with diabetes
mellitus, self-reported health status and comorbidities including hypertension,
hypercholesterolemia, CVD, obesity, and depression. These potential confounders have all been
shown to be associated with adherence to self-management in people with diabetes mellitus (41,
51, 65, 94, 95). Previous studies have shown that insulin use and formal diabetes mellitus
education modify the association between a diabetes self-management behavior and the
performance of diabetes mellitus preventive care processes (65, 93, 94). Thus, this study
assessed insulin use and receipt of diabetes mellitus education as potential effect modifiers.

Statistical Analysis
All analyses were conducted with adjustments for the complex sample design of the
BRFSS to provide population estimates that represent the 38 states that participated in the 2015
Diabetes Mellitus Optional Module (82). Descriptive statistics for the total study population and
stratified by who received and did not received the ADFSE, were calculated for all variables.
The sub-populations were compared through chi-squared tests to determine if statistically
significant differences existed between the study groups.
Eight separate multivariable logistic regression models were evaluated to assess the
association between each of the self-management behaviors and the ADFSE.

Hierarchical

backward elimination was conducted to identify a parsimonious model for each self-management
behavior (96). Initial models contained a single self-management behavior, all covariates, all
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confounders and both effect modifiers. First, one-way effect modifications, by status of insulin
use or receipt of diabetes mellitus education, were assessed. Full and reduced models were
compared using the likelihood ratio test where p<0.05 was considered a significant difference
between models. Significant interactions (p<0.05) were retained in the model and the results
were stratified by the effect modifier for reporting. Following assessment for effect
modification, confounding was assessed using the 10% change-in-estimate method (96).
Sensitivity analyses were conducted for each model to determine the potential for bias
due to non-response to the study outcome of interest. For this analysis, the 1,965 respondents,
originally excluded for an invalid response to the outcome question, were classified as either all
having had the ADFSE or all not having had the ADFSE. The final models for each of the eight
self-management behaviors were then re-calculated to determine the odds ratios and 95% CIs
assuming the missing respondents did or did not receive the ADFSE. All analyses for this paper
were generates using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).

RESULTS
Table 1 presents the weighted percentages of the characteristics of the study population
(n=14,823). In 2015, 78.3% of persons aged 18 years and older, with diagnosed diabetes
mellitus and at least one visit to a healthcare provider for diabetes mellitus care received at least
ADFSE in the past 12 months. Fifty-one and nine-tenths percent (59.1%) of the population with
diabetes mellitus were male, 59.4% were under the age of 65 years and 60.1% were nonHispanic white. Nearly 95% of people with diabetes mellitus had some form of health insurance.
A majority of the study population reported having hypertension (71.9%) and high cholesterol
(64.3%), while 24.2% reported some type of CVD and 23.9% reported having depression. A
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majority of the study population received formal diabetes mellitus education (59.0%), reported
time since diagnosis of diabetes mellitus of 10-19 years (34.8%) and “good” or better self-rated
health (55.1%).
Table 3-1- Characteristics of persons aged ≥18 years with diagnosed diabetes, 38 states (n=14,823)*
Received annual diabetes foot screening
P value‡
Study population
exam in past 12 months
Yes
No
78.3±1.10%†
21.7±1.10 %†
%
SE
%
SE
%
SE
Sex
Male
51.9
1.3
52.7
1.4
49.1
2.9
0.273
Female
48.1
1.3
47.3
1.4
50.9
2.9
Age (years)
18-64
59.4
1.2
58.0
1.4
64.7
2.7
0.0322
≥65
40.6
1.2
42.0
1.4
35.3
2.7
Race
Non-Hispanic white
60.1
1.4
61.5
1.5
54.7
3.1
0.0016
Non-Hispanic black
15.0
0.8
15.9
0.9
11.7
1.4
Hispanic
16.9
1.4
14.6
1.4
25.2
3.5
Other
5.0
1.1
7.9
1.3
8.4
1.8
Education
Less than high school
18.6
1.2
17.7
1.3
22.0
3.2
0.2376
High school graduate
29.5
1.0
29.2
1.1
30.6
2.6
Some college
31.9
1.2
33.0
1.3
28.1
2.3
College graduate
20.0
1.0
20.1
1.2
19.3
2.0
Marital status
Married
62.5
1.1
62.5
1.2
62.5
2.5
0.9332
Divorced/separated
16.6
0.7
16.6
0.8
16.5
1.6
Widowed
12.1
0.6
12.2
0.6
11.6
1.2
Never married
8.8
0.5
8.7
0.6
9.4
1.3
Annual household income
<$15,000
15.4
1.0
15.0
1.1
16.4
2.4
0.1546
$15,000-<$25,000
21.9
1.1
20.8
1.1
26.0
3.0
$25,000-<$35,000
12.3
0.8
12.1
0.8
13.0
1.8
$35,000-<$50,000
13.1
0.6
13.4
0.7
11.8
1.4
≥$50,000
37.5
1.3
38.8
1.4
32.8
2.5
Health insurance
Yes
93.9
0.8
94.5
0.9
91.8
1.8
0.1350
No
6.1
0.8
5.5
0.9
8.2
1.8
Use insulin
Yes
34.0
1.1
36.8
1.3
23.8
2.3
<0.0001
No
66.0
1.1
63.2
1.3
76.2
2.3
Received diabetes mellitus
education
Yes
59.0
1.2
62.1
1.3
47.7
3.0
<0.0001
No
41.0
1.2
37.9
1.3
52.3
3.0
Time since diagnosis with
diabetes mellitus
0-4 years
18.4
1.0
16.0
1.0
27.2
2.4
<0.0001
5-9 year
17.4
1.0
17.9
1.1
15.7
1.4
10-19 years
34.3
1.3
33.8
1.4
36.3
3.2
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20-29 years
15.5
0.9
15.8
1.1
9.5
1.3
30+ years
15.4
0.7
16.5
0.8
11.3
1.4
Self-reported health status
Excellent
2.5
0.3
2.5
0.3
2.3
0.4
0.9722
Very good
16.5
0.8
16.7
0.9
15.8
1.9
Good
36.1
1.2
35.8
1.3
37.1
2.7
Fair
30.4
1.2
30.3
1.3
30.8
3.1
Poor
15.6
1.1
14.7
1.3
13.9
1.6
Hypertension
Yes
71.9
1.3
72.7
1.4
68.9
3.0
0.2468
No
28.1
1.3
27.3
1.4
31.1
3.0
High cholesterol
Yes
64.3
1.3
64.5
1.5
63.8
3.0
0.8531
No
35.7
1.3
35.5
1.5
36.2
3.0
Cardiovascular disease
Yes
24.2
1.0
25.6
1.2
19.0
1.7
0.0019
No
75.8
1.0
74.4
1.2
81.0
1.7
Depression
Yes
23.9
1.0
23.5
1.1
25.0
2.1
0.5241
No
76.1
1.0
76.5
1.1
75.0
2.1
Visits to health provider for
diabetes mellitus care
<0.0001
1 visit
16.0
0.9
13.4
0.8
25.4
2.4
2 visits
23.5
1.2
23.0
1.2
24.5
3.1
3 visits
16.7
1.0
16.9
1.1
15.6
1.6
4 visits
27.4
1.1
29.9
1.3
18.5
2.2
5+ visits
16.4
1.0
16.8
1.2
15.1
1.9
BMI
Underweight
0.5
0.1
0.4
0.1
0.5
0.5
0.4907
Normal
12.7
0.8
12.8
0.9
12.3
1.6
Overweight
32.9
1.3
32.9
1.5
32.8
2.8
Obese
53.9
1.3
53.9
1.4
53.9
2.9
* The 38 states include: Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida,
Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota,
Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma,
Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington,
Wisconsin, and Wyoming. † Percentage of population ± SE. ‡ P-values from χ2 test.

Examining the population who received the ADFSE, we found that 52.7% were male and
58.0% were under the age of 65 and 94.5% had some form of health insurance. The distribution
of race in those who received the ADFSE was: 61.5% non-Hispanic white, 15.9% non-Hispanic
black, 14.6% Hispanic and 7.9% reported another race. A majority of patients who received the
ADFSE received at least some college level education (53.1%), were married (62.5%), reported
an annual household income over $35,000 (52.2%), have had diabetes more than 10 years
(66.1%), reported at least “good” self-rated health (55.0%) and reported 3 or more visits to a
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healthcare provider for diabetes care (63.6%). Among those who received the ADFSE, 72.7%
had hypertension, 64.5% have high cholesterol, 25.6% report CVD, 23.5% have depression and
86.8% were overweight or obese.
The population who did not receive the ADFSE were 49.1% male, 64.7% were under the
age of 65 and 91.8% had health insurance. Upon examining race, of those who did not receive
the ADFSE 54.7% were non-Hispanic white, 11.7% were non-Hispanic black, 25.2% were
Hispanic and 8.4% were of other races. A majority of the population who did not receive the
ADFSE had less than a high school level education or only graduated from high school (52.6%),
were married (62.5%), and had an annual income less than $35,000 (55.4%), have had diabetes
over 10 years (57.1%), reported at least “good” self-rated health (55.2%) and reported having 3
or more visits to a healthcare provider for diabetes care (50.1%). When comorbidities are
explored, 68.9% had hypertension, 63.8% have high cholesterol, 10% report having CVD, 25.0%
have depression and 86.7% are overweight or obese.
Table 2 presents the reported performance of recommended diabetes self-management
behavior in the study population. The two most often performed behaviors were SMBG at least
one time per day (89.9%) and self-foot exam at least one time per day (87.4%). The two least
commonly performed behaviors are currently smoking (13.4%) and drinking excessive amounts
of alcohol (2.1%). The rates of performance of the other diabetes self-management behaviors
were: 59.0% received the influenza vaccine in the past 12 months, 61.6% have received a
pneumococcal vaccine, 44.2% met aerobic activity recommends and 19.6% met resistance
training recommendations.

29

Table 3-2- Reported performance of recommended diabetes mellitus self-management behaviors
in persons aged ≥18 years with diagnosed diabetes, 38 states (n=14,823)*
Received annual diabetes foot screening
exam in past 12 months
Yes
No
78.3±1.10%†
21.7±1.10 %†
%
SE
%
SE

Study population

P value‡

%
SE
Perform self-monitoring of
0.0004
blood glucose ≥1 time per
day
Yes
89.9
0.7
91.2
0.8
85.4
1.5
No
10.1
0.7
8.8
0.8
14.6
1.5
Perform self-foot exam ≥1
<0.0001
time per day
Yes
87.4
0.7
90.7
0.7
75.3
2.1
No
12.6
0.7
9.3
0.7
24.7
2.1
Receive influenza vaccine
0.0272
in past 12 months
Yes
59.0
1.3
60.5
1.4
53.5
2.9
No
41.0
1.3
39.5
1.4
46.5
2.9
Ever receive pneumococcal
<0.0001
vaccine
Yes
61.6
1.3
64.7
1.4
50.3
2.9
No
38.4
1.3
35.3
1.4
49.7
2.9
Met aerobic activity
0.0217
recommendations§
Yes
44.2
1.3
45.7
1.4
38.7
2.7
No
55.8
1.3
54.3
1.4
61.3
2.7
Met resistance training
0.0193
recommendations||
Yes
19.6
1.0
20.8
1.2
15.2
1.9
No
80.4
1.0
79.2
1.2
84.8
1.9
Current smoking status
0.8249
Yes
13.4
0.9
13.3
1.1
13.8
1.6
No
86.6
0.9
86.7
1.1
86.2
1.6
Excessive alcohol
0.0323
consumption¶
Yes
2.11
0.3
2.3
0.4
1.3
0.3
No
97.9
0.3
97.7
0.4
98.7
0.3
* The 38 states include: Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida,
Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota,
Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma,
Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington,
Wisconsin, Wyoming.. † Percentage of population ± SE. ‡ P-values from χ2 test. § ≥150 minutes of moderate
aerobic exercise per week. || Perform resistance training ≥2 days per week. ¶ Males- no more than 2 and women
no more than 1 alcoholic beverage per day.

When only those who received the ADFSE are examined, 91.2% complete SMBG at
least one time per day and 90.7% perform a self-foot check at least one time per day. This
population reports rates of smoking (2.3%) and excessive alcohol consumption (13.3%) at higher
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rates than the general population with diabetes. Of the ADFSE recipients 60.5% received the
influenza vaccine in the past 12 months, 64.7% received the pneumococcal vaccine, 45.7%
performed the recommended amount of aerobic activity and 20.8% performed the recommended
amount of resistance training.
Reported rates of SMBG at least one time per day (85.4%) and self-foot exams at least
one time per day (75.3%) were lower among those who did not receive the ADFSE. The other
rates of completion were also lower in the population who did not receive the ADFSE. The
influenza vaccine was received by only 53.5% and pneumococcal vaccine was received by
50.3% of those who did not also receive the ADFSE. Finally, only 38.7% and 15.2% of patients
performed the recommended amounts of aerobic and resistance training, respectively.
Table 3 shows the results from the 8 multiple logistic regression models to describe the
association between each diabetes mellitus self-care behaviors and the performance of the
ADFSE. The status of insulin use was found to modify the association between receipt of the
influenza vaccine (p=0.006), performance of the recommended dosage of aerobic exercise
(p=0.036) and avoidance of excessive alcohol consumption (p=0.034) and performance of the
ADFSE.
The receipt of the influenza vaccine and the performance of the recommended dosage of
aerobic exercise did not demonstrate significant associations with the performance of the
ADFSE, in either subpopulation. A positive association was found in the population that do not
use insulin and consume an excessive quantify of alcohol. Among those who do not use insulin
and do consume an excessive amount of alcohol there is more than 3 times increased odds (OR:
3.14, 95%CI: 1.45-3.91) ADFSE is performed compared to those who do not use insulin and
avoid excessive alcohol usage.
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Table 3-3- Multiple Logistic Regression Model Estimates of Odds Ratios (OR) and 95% CI for the
association between patient performance of 8 individual diabetes mellitus self-management behaviors on
the performance of the recommended annual diabetes foot screening examination (n=14,823)
Recommended selfEffect modification
Self-management behavior
management behavior
Met recommendation
Did not meet
recommendation OR
(95% CI)
Use insulin
Reference
1.67 (0.79-2.43)
Do not use insulin
Reference
0.52 (0.38-0.82)
Self-monitor blood
Had diabetes mellitus
Reference
0.19 (0.09-0.94)
glucose ≥1/per day*
education
No diabetes mellitus
Reference
0.52 (0.36-0.74)
education
Perform self-foot check
None
Reference
0.33 (0.25-0.44)
≥1/per day†
Use insulin
Reference
1.78 (0.86-2.50)
Received influenza
vaccine ≤12 months*
Do not use insulin
Reference
0.90 (0.68-1.19)
Ever receive
None
Reference
0.59 (0.45-0.76)
pneumococcal vaccine*
Perform ≥150 minutes of
Use insulin
Reference
1.60 (0.75-2.36)
moderate aerobic exercise
Do not use insulin
Reference
0.90 (0.69-1.18)
per week*
Perform resistance
training ≥2 days per
None
Reference
0.71 (0.51-0.98)
week*
No smoking*
None
Reference
0.95 (0.69-1.30)
Avoid excessive alcohol
Use insulin
Reference
0.86 (0.31-1.87)
consumption‡
Do not use insulin
Reference
3.14 (1.45-3.91)
Bolded ORs and 95% CI indicate significance at p<0.05. All models adjusted for covariates: sex, age, race,
education, marital status, annual household income and insurance status. *Adjusted for covariates only. †
Adjusted for covariates and duration of time with diabetes mellitus. ‡ Adjusted for covariates and number of
visits to a health provider for diabetes mellitus care.

Both status of insulin use (p=0.0108) and of the receipt of formal diabetes education
(p=0.0336) were found to be significant effect modifiers of the relationship between performance
of SMBG at least one time per day and the receipt of the ADFSE. Among those who used
insulin, performance of SMBG was not significantly associated with the performance of the
ADFSE (OR: 1.67, 95%CI: 0.79-2.43). For the group that does not use insulin, those who do not
perform SMBG at least one time per day were nearly 50% less likely to receive the ADFSE (OR:
0.52, 95%CI: 0.38-0.82) compared to those who do perform SMGB at least one time per day.
When effect modification based on receipt of formal diabetes education was explored, both
statuses demonstrated a significant association between performance of SMBG at least one time
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per day and performance of the ADFSE. Among those who receive formal diabetes education,
those who do not perform SMBG at least one time per day were more than 20% less likely to
receive the ADFSE (OR: 0.19, 95% CI: 0.09-0.94) compared to those who do perform the
behavior. Finally, those who do not receive formal diabetes and do not perform the SMBG
activity nearly 50% less likely to receive the ADFSE (OR: 0.52, 95%CI: 0.36-0.74) compared to
those who perform SMBG at least one time per day.
No statistically significant one-way effect modifications were demonstrated between the
remaining four self-management behaviors (perform daily self-foot check, receipt of
pneumococcal vaccine, resistance exercise and smoking status) and performance of the ADFSE.
The model results demonstrated that not performing daily self-foot checks, non-receipt of the
pneumococcal vaccination and not performing the recommended dosage of resistance exercise
all have a negative association with the receipt of the ADFSE. Those who do not perform a daily
self-foot check are 67% less likely (OR: 0.33, 95%CI: 0.25-0.44) to receive the ADFSE
compared to those who do perform a daily self-foot check. Those who do not receive a
pneumococcal vaccination are nearly 40% less likely (OR: 0.59, 95%CI: 0.45-0.76) to receive
the ADFSE compared to those who have received the vaccination. And those who do not
perform resistance training at least 2 times week, are almost 30% less likely (OR: 0.71, 95%CI:
0.51-0.98) to receive the ADFSE, compared to those who perform the recommended dosage of
resistance training. Finally, no significant association (OR: 0.95, 95%CI: 0.69-1.30) was found
between current smoking status and receipt of the ADFSE.
Finally, Table 4 presents the results of the sensitivity analysis for non-response bias. The
results demonstrfate no significant non-response bias.
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Table 3-4- Multiple logistic regression model estimates of odds ratios (OR) and 95% CI to assess
for outcome non-response bias in estimates for the influence of patient performance of 8
individual diabetes mellitus self-management behaviors on the performance of the recommended
annual diabetes foot screening examination.
Model estimate
OR (95% CI)

Assuming all
non-responders
received ADFSE
OR (95% CI)

Assuming no
non-responders
received ADFSE
OR (95% CI)

Perform self-monitoring of blood glucose ≥1 time per
day
Use insulin, received diabetes mellitus education
No insulin use, received diabetes mellitus education
Use insulin, no diabetes mellitus education
No insulin use, no diabetes mellitus education

0.62 (0.17-1.27)
1.67 (0.54-5.15)
0.19 (0.07-0.50)
0.52 (0.36-0.74)

0.54 (0.15-1.96)
1.43 (0.53-3.86)
0.22 (0.10-0.48)
0.57 (0.40-0.80)

0.51 (0.11-2.40)
1.34 (0.44-4.14)
0.21 (0.08-0.56)
0.57 (0.39-0.82)

Perform self-foot exam ≥1 time per day

0.33 (0.25-0.44)

0.39 (0.30-0.51)

0.40 (0.30-0.51)

Receive influenza vaccine in past 12 months
Use insulin
No insulin use

1.78 (0.86-2.50)
0.90 (0.68-1.19)

1.38 (0.81-1.91)
0.84 (0.64-1.10)

1.39 (0.83-1.91)
0.86 (0.66-1.12)

Ever receive pneumococcal vaccine

0.59 (0.45-0.76)

0.58 (0.45-0.74)

0.59 (0.46-0.75)

Met aerobic activity recommendations*
Use insulin
No insulin use

1.60 (0.75-2.36)
0.90 (0.69-1.18)

1.50 (0.92-1.98)
0.90 (0.69-1.16)

1.53 (0.96-2.00)
0.92 (0.71-1.18)

Met resistance training recommendations†

0.71 (0.51-0.98)

0.72 (0.55-1.00)

0.76 (0.57-1.01)

Current smoking status

0.95 (0.69-1.30)

0.94 (0.69-1.28)

0.93 (0.69-1.25)

Excessive alcohol consumption ‡
Use insulin
0.86 (0.31-1.87) 0.66 (0.33-1.34) 0.69 (0.36-1.36)
No insulin use
3.14 (1.45-3.91) 2.16 (1.12-2.81) 2.14 (1.12-2.79)
* ≥150 minutes of moderate aerobic exercise per week. † Perform resistance training ≥2 days per week. ‡ Malesno more than 2 and women no more than 1 alcoholic beverage per day

CONCLUSIONS
The results of this study support the hypothesis that a positive association exists between
the performance of some diabetes mellitus self-management behaviors and the receipt of the
ADFSE among the US population with diabetes mellitus. The daily performance of SMBG and
self-foot checks, receipt of the pneumococcal vaccination, and performance of resistance training
at least two days per week were all significant and positively associated with the performance of
the ADFSE. In contrast, a negative association between receipt of the ADFSE and those who
avoid excessive alcohol. While this association is opposite of that found among the other
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significant self-management behaviors, it may be explained by the development of PN among
those who consume excessive alcohol, providing a different trigger for a foot inspection (97).
We also found some associations between self-management behaviors and receipt of the
ADFSE were modified by status of insulin use and receipt of formal diabetes mellitus education.
Our results are consistent with findings from prior literature (65, 93, 94). In the early 2000s
national estimates from BRFSS data demonstrated the receipt of the ADFSE varied among subpopulation based on both insulin use and receipt of formal education (93). In this study, the rates
of performance of the ADFSE were higher among those who used insulin compared to those
who did not use insulin as well as among those who received formal diabetes mellitus education
compared to those who did not. Rates of performing self-management behaviors were also
higher in the sub-populations that used insulin and received formal education. Among AsianAmericans with diabetes mellitus use of insulin was also found as an effect modifier (65). Those
who use insulin in the Asian-American population were more likely to receive preventive care
processes, including the ADFSE, compared to those who did not use insulin. Given the
consistency of effect in this study and other literature, it is apparent that future research should
continue to explore the underlying causes for such variations and develop effective intervention
programs that target at the subgroups of patients who are currently not benefiting from the
ADFSE.
Given the ADFSE is intended to prevent DFUs and, ultimate, LEAs, it is important to
consider if the diabetes mellitus self-management behaviors found to be associated with the
performance of the ADFSE in this study, also influence the rates of DFUs and LEAs in the US.
A 2014 study conducted by Margolis, et al. found LEA rates in the US may be explained, in part,
by variations in patient health behaviors, including diabetes mellitus self-management behaviors
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and receipt of cancer screenings (92). Our results indicate that performance of some diabetes
mellitus self-management behaviors, may influence the performance of the ADFSE. It is
possible that the ADFSE is a link between the self-management behaviors and the lower rates of
LEAs. However, as proposed by Margolis, et al. our results may also be an indication of the
level of health literacy among patients with diabetes mellitus. Patients with diabetes mellitus
that have a higher level of health literacy are more likely to complete recommended selfmanagement behaviors and gain more benefit from healthcare interventions (98, 99). Thus, it is
possible, that those with higher health literacy ensure the receipt of the ADFSE and follow DFU
prevention recommendations resulting in lower rates of LEAs. Further research is needed to
assess the role health literacy plays in DFU and LEA prevention and management.
As with other observational studies, this study is limited by the self-reported nature of the
data which may introduced of recall, misclassification and possibility social desirability biases.
The cross sectional nature of the data also limits the determination of causality. One major
limitation is the survey question utilized to define this study’s outcome measure. The
comprehensive ADFSE involves multiple components including a neurologic and vascular exam
as well as visual inspection of the feet. The BRFSS question only asks “has a health professional
checked your feet for any sores or irritations?” This implies a visual exam was completed but
there is no indication if the neurologic and vascular exams were completed. Thus, the outcome
may be an overestimation of the true rate of the complete clinical ADFSE (40). Another major
limitation is the inability to discern if a participant has T1DM or T2DM. Given the differences
in disease management these populations should be considered separately in future analyses (4).
Prior research has also identified provider type can influence the performance of preventive
health services but this data is not available in the BRFSS data (100-102).
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Despite these limitations, this was the first study, to our knowledge, to systematically
explore the association between individual diabetes mellitus self-management behaviors and
receipt of the recommended ADFSE using a large, population based data set representing a
majority of US states. Thus, it provides results that are generalizable to the US population with
diabetes mellitus within the 38 states captured in the BRFSS Diabetes Mellitus Optional Module.
The main outcome of this study, the performance of the ADFSE, is based upon the same BRFSS
survey question utilized by Healthy People 2020 to report national rates of completion of the
ADFSE increasing the external validity of our study (91). Research has also found good
agreement between self-report of the ADFSE on the BRFSS and chart audits increasing the
internal validity (43, 103).
In conclusion our study provides support to the Piette and Kerr conceptual model which,
in part, considers the influence of patient self-management behaviors on the clinical care of
patients with diabetes mellitus. We found that five diabetes mellitus self-management behaviors
are positively associated with the performance of the ADFSE, an effective and cost-effective
screening exam that is known to reduce DFUs and LEAs. Future research must focus on
demonstrating a causal relationship among diabetes mellitus self-management behaviors,
performance of the ADFSE and ultimately, the prevention of DFUs and LEAs in the US
population with diabetes mellitus. If this causal relationship can be proven, existing programs
aimed at improving self-management in patients with diabetes mellitus, such as Lifestyle
Redesign® with an occupational therapist, could offer a solution to the problem of DFUs and
LEAs (104). The reduction of DFUs and LEAs in the ever increasing US population with
diabetes mellitus would improve the quality of life of patients and reduce the financial burden on
both patients and the US healthcare system.
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CHAPTER 4: The Association Between Comorbidities and the Performance of the
Recommended Annual Diabetes Foot Screening Examination
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ABSTRACT
Objective: This study aimed to assess the simultaneous, direct effects of concordant and
discordant comorbidities on the performance of the annual diabetes foot screening exam
(ADFSE), using structural equation modeling (SEM), to simulate clinical decision making.
Research Design and Methods: We used the 2015 BRFSS data from 38 states (n=20,882) to
conduct a cross-sectional study. Respondents who provided a valid response regarding receipt of
the ADFSE and had at least one visit to a health care provider in the past 12 months were
included. SEM was used to assess the simultaneous, direct effects of concordant and discordant
comorbidity loads on the performance of the ADFSE.
Results: In 2015, 78.2% of patients with diabetes received the ADFSE. Hypertension (71.0%)
was the most commonly and renal disease (8.2%) was the least commonly reported
comorbidities. On average, patients with diabetes have 4.8 comorbidities. The final SEM model
demonstrated that neither concordant comorbidities (β=0.226, p=0.086) nor discordant
comorbidities (β=0.080, p=0.415) had a direct association with the performance of the ADFSE.
Conclusions: The burden of concordant and discordant comorbidities are not associated with the
performance of the ADFSE. This may be a reflection of recent changes in the US healthcare
system, such as the introduction of clinical practice guidelines and incentive payments for quality
of care, including the performance of the ADFSE in the US population with diabetes. However,
in light of the burden DFUs and LEAs place on patient quality of life and the financial burden on
the US healthcare system, identification of other influential factors and development of
interventions to increase the rate of the ADFSE in the US may be the only way to reduce the
rates of DFUs and LEAs in the US and the world.
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INTRODUCTION
The management of patients with DFUs costs the American health care system $9-13
billion dollars annually and significantly increases utilization of emergency, inpatient and
outpatient medical services (15). When treatment fails patients must undergo an LEA, with more
than 85% of all amputations in the US being preceded by a DFU (21). With the prevalence of
diabetes expected to increase and affect 21-34% of the US population by 2050, and the lifetime
incidence of a DFU in this population as high as 34%, the costs of DFU management and rates of
LEAs will likely increase (3, 23). However, evidence has shown that up to 75% of DFUs and
more than 49% of LEAs are preventable through cost-effective, comprehensive screening exams
and prevention programs (31, 32). It is essential that all individuals with diabetes receive the
recommended ADFSE (33, 36). Despite the known benefits, in 2015, only 71.6% of the US
population with diabetes received the ADFSE (88).
The management of patients with diabetes includes 11 recommended preventive care
processes, including the ADFSE, that are now a incorporated in quality of care processes
measures in the US (105, 106). Table 1 presents the 11 recommended diabetes care processes
and the reported rates of completion in the US in 2015. However, the medical management of
patients with diabetes is further complicated by the presence of other comorbidities. Therefore,
quality of care for patients with diabetes must also consider the management of comorbidities. .
As discussed in the Piette and Kerr conceptual framework on competing demands of chronic
comorbid conditions in diabetes care the need to complete diabetes care processes, including the
ADFSE, competes with the need to complete self-management and clinical screenings for other
comorbidities (50). Within the time of an often brief clinical visit, health care providers must
prioritize required preventive care processes along with management of patient comorbidities
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and other patient reported symptoms. Often the care of more complex or serious medical
conditions, such as cancer, renal failure or symptomatic depression, preclude the performance of
preventive care, such as the ADFSE (50).
Table 4-1- Recommended diabetes preventive care processes and Healthy People 2020 reported results(62,
105, 106)

Preventive care process

Healthy People 2020
report year

HgbA1c measurement at least twice a year
LDL cholesterol measurement every 1-2 years
At least annual blood pressure measurement
Annual urinary microalbumin measurement
Annual diabetes foot examination
Annual dilated eye examination
Annual dental examination
Annual flu vaccination
Annual pneumococcal vaccination
Hepatitis B vaccination series
Annual evaluation of footwear

2007
NR*
NR*
2012
2007
2008
2014
NR*
NR*
NR*
NR*

US diabetes
population receiving
preventive care
process
64.8%
NR*
NR*
42.4%
70.2%
53.4%
54.5%
NR*
NR*
NR*
NR*

* NR- no report: not included in Healthy People 2020 or not specifically reported for diabetes population

A majority of patients with diabetes must also manage at least one other chronic
comorbid medical condition, such as hypertension or CAD (66). National estimates, published in
2014, indicate that amongst those with diabetes in the US, nearly 85% were overweight or obese,
57% had hypertension and over 58% had hypercholesterolemia. In those aged 35 and over with
diabetes, CAD and MI affect nearly 22%, while over 9% have suffered a CVA (67). A study
from 2015 reported nearly 90% of patients with diabetes had at least one other comorbidity
(107). The study also reported 37% of patients with diabetes had one to two other comorbidities
while 43% had three to four. Given these high rates of comorbidities and multiple concurrent
comorbidities, it is imperative to understand how they compete with diabetes quality of care, in
particular, the ADFSE.
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Prior research has explored the relationships between individual comorbidities or the total
number of comorbid conditions with the performance of a number of the recommended diabetes
preventive care processes. Studies have found individual comorbidities have differential effects
on diabetes preventive care processes (55, 70). A study utilizing a total count of comorbidities
found patients with more than five comorbidities had an increased odds of receiving HgbA1c
testing and annual dilated eye exams (68). Piette and Kerr introduced a system to classify
comorbidities as either concordant or discordant with diabetes disease management and
preventive care processes (50). Using this classification scheme studies have again found
differential effects on recommended diabetes preventive care processes (52, 71). While studies
demonstrated both positive and negative associations between individual comorbidities and total
number of comorbidities, to date, no US study has explored the relationship between
comorbidities and the ADFSE.
Thus far, the literature has suggested that the counts, individual comorbidities, and types
of comorbidities may all exert an influence on the performance of some of the recommended
diabetes preventive care processes. There is also a lack of research among the US population
exploring the relationship between comorbidities and the ADFSE. Thus, we proposed to address
this gap in the literature for the ADFSE while considering the number and types of
comorbidities, as well as the individual contribution of specific comorbidities to simulate the
clinical decision making process. Health care providers must consider comorbidity
interrelatedness, or the interaction of medical conditions and treatments, when conducting
clinical exams (108). Therefore, this study aimed to assess the simultaneous, direct effects of
concordant and discordant comorbidities on the performance of the ADFSE, using structural
equation modeling (SEM), to simulate clinical decision making.
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RESEARCH DESIGN AND METHODS
Data Source and Sample
This study utilized data from the 2015 BRFSS (81). The BRFSS is an annual crosssection survey, administered by the CDC that interviews non-institutionalized US residents, over
the age of 18. The BRFSS is designed to collect data on preventive health practices, health risk
behaviors, and chronic disease that affect the US adult population. The methods for sample
design and sampling weighting to account for complex sample design are described elsewhere
(82).
The 2015 BRFSS included an option module focused on diabetes which included 10
questions specific to diabetes care. In 2015, the 38 states that participated in the Diabetes
Optional Module included: Arizona, California, Colorado, Connecticut, Delaware, District of
Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana,
Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey,
New Mexico, New York, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South
Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming. This
module was administered to all respondents, in participating states, who answered “yes” to the
question “Has a doctor, nurse or other health professional every told you that you have
diabetes?” in the BRFSS core component. Respondents indicating the diagnosis of gestational,
borderline or pre-diabetes were excluded from the Diabetes Optional Module in the BRFSS
survey design. A total of 36,085 of the 2015 BRFSS participants were eligible to participate in
the Diabetes Optional Module.
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The inclusion criteria for this study required respondents have at least one foot, have had
at least one visit to a health care provider for diabetes specific care within in the past 12 months
and provided valid responses to all exposure and confounding variables. The BRFSS contains a
question requesting respondents indicate “About how often do you check your feet for any sores
or irritations?” (90). Those who gave a response of “no feet” (n=349) were excluded from the
analytic sample. The question “About how many times in the past 12 months have you seen a
doctor, nurse or other health professional for your diabetes?” was utilized to identify all
respondents who had at least one visit to a healthcare provider for diabetes care. Those who
reported having no visits or did not provide a valid response to this question were excluded from
the analytic sample (n=3,656). Finally respondents who did not provide valid answers to all
exposure and confounding variable questions were also excluded (n=11,198). The final analytic
sample size for this study was 20,882.

Measures
The ADA and the IWGDF recommend patients with diabetes receive the ADFSE at least
one time per year and this was defined as the outcome for this study (33, 36). The outcome was
operationalized using the BRFSS question “About how many times in the past 12 months has a
health professional checked your feet for any sores or irritations?” The respondents provided the
number of times, on a continuous scale from 1-76, or “none.” The responses were dichotomized,
for this study, to “at least one ADFSE” and “none.”
The main exposures of this study are two latent variables, “diabetes concordant
comorbidity burden” and “diabetes discordant comorbidity burden.” These latent variables are
measured by observed variables for individual comorbid medical conditions. The 2015 BRFSS

44

contains information on the diagnoses of hypertension, high cholesterol, MI, CAD, CVA,
asthma, cancer, pulmonary diseases, orthopedic conditions, depressive disorder, renal disease,
diabetic retinopathy and overweight or obese. The assignment of indicators, the individual
comorbidities, to each of the latent variables will be based upon the classifications from a Delphi
study by Magnan et al. from 2015 (53). The concordant comorbidities will be defined by
indicators for the presence or absence of hypertension, high cholesterol, MI, CAD, CVA, renal
disease, retinopathy and overweight or obese. The discordant comorbidities will be defined by
indicators for asthma, respiratory diseases, cancer, orthopedic diseases, and depressive disorders.
The indicator for hypertension was derived from the survey question “have you ever been
told by a doctor, nurse or other health professional that you have high blood pressure?” (90).
Respondents answering “yes” were categorized as having hypertension. For consistency with
prior studies, female respondents indicating hypertension only during pregnancy and all
respondents indicating “borderline high” or “pre-hypertension” will be categorized as not having
hypertension (109-111).
All cancer diagnoses, including skin cancer, were combined into one variable, consistent
with the results of a Delphi study conducted by Magnan, et al. (53). Respondents answering
“yes” to either “have you ever been told by a doctor, nurse or other health professional that you
had skin cancer?” or “Ever told you had any other types of cancer?” will be classified as having
cancer. Respondents answering “no” to both questions will be considered to never have had
cancer.
The BRFSS created variables to identify adults who currently have asthma and another
which calculated BMI (90).

The variable to identify adults who have been told they currently

have asthma categorized respondents as either “yes, currently have asthma” or “no.” The
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calculated variable for BMI was retained as a continuous variable for the analysis. Respondents
with calculated BMI equal to or more than 25.0 will be classified as overweight/obese.
Respondents with BMI less than 25.0 will be classified as not overweight/obese.
Finally, the indicators for high cholesterol, MI, CAD, CVA pulmonary diseases,
orthopedic conditions, depressive disorder, renal disease and diabetic retinopathy were
constructed from a series of questions with the stem “have you ever been told by a doctor, nurse
or other health professional that you had [chronic condition]?” (90). A response of “yes” to each
condition was categorized as having the chronic condition and responses of “no” as not having
the chronic condition. The BRFSS question for pulmonary diseases included the diagnoses of
chronic obstructive pulmonary disease (COPD), emphysema and chronic bronchitis. The
question for orthopedic conditions includes the diagnoses of rheumatism, polymyalgia
rheumatica, osteoarthritis, tendonitis, bursitis, bunion, tennis elbow, carpal tunnel syndrome,
tarsal tunnel syndrome and joint infections.
Potential confounders for the study, based on prior research, included: respondents age
(<65/≥65 years old), gender (male/female), race (White non-Hispanic, Black non-Hispanic,
Hispanic, or other), education (did not graduate high school, graduated from high school ,
attended college or technical school, or graduated from college or technical school), marital
status (married/member of an unmarried couple, divorced/separated, widowed or never married),
annual household income (<$15,000, $15,000- <$25,000, $25,000- <$35,000, $35,000<$50,000, ≥$50,000), insurance status (insured/uninsured), insulin use (yes/no) and receipt of a
diabetes education course (yes/no) (47, 51, 52, 54, 55, 71).
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Statistical Analysis
Descriptive statistics for the outcome, all exposures and potential confounders were
calculated. This included analyses stratified based on receipt of the ADFSE. All proportions
and means were weighted to provide population level estimates based on the complete sample
design of the BRFSS. Chi-squared or student’s t-test were utilized to compare groups.
SEM methods, using the two step approach, were used to assess the simultaneous, direct
effects each of the latent variables, concordant and discordant comorbidities, have on the
performance of the ADFSE. First, confirmatory factor analysis (CFA) was conducted to assess
the goodness-of-fit of the measurement model. A good model fit was defined by a root mean
squared error of approximation (RMSEA) less than 0.05 and a Comparative Fit Index (CFI)
greater than 0.95 (112). If a CFA model was found to not be a good fit of the data, standardized
solutions for between each indicator and the associated latent variable were calculated to
determine the correlations. Indicators with poor correlation (p<0.2) to the latent variable were
removed from the model. The reduced CFA model was then reanalyzed for goodness-of-fit.
Once the measurement model demonstrated a good fit with the data, final correlations and
variance explained by each indicator were determined.
Once an acceptable measurement model was determined through CFA, probit structural
regression modeling was undertaken to assess the full model 1. First, potential confounders were
determined by calculating the odds ratio and 95% CI between each potential confounder and the
outcome. Confounders were included in the final model if the bivariate association was
significant (p<0.05). The final model, with confounders, was assessed using structural
regression modeling. Model goodness-of-fit was first assessed utilizing RMSEA less than 0.05
and CFI greater than 0.95.
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All analyses were conducted with adjustment for the complex sample design of the
BRFSS. Proportions and means represent national estimates and include standard error
estimations (82). Data analyses were generates using SAS version 9.4 (SAS Institute Inc., Cary,
NC, USA) and MPlus version 9 (Muthén & Muthén, Los Angeles, CA, USA).

RESULTS
In 2015, 78.2% of the US population with diabetes and at least one visit to a health care
provider for diabetes care reported receipt of the ADFSE. The demographic characteristics of
the total study population (n=20,882), and the study population stratified by receipt of the
ADFSE, are presented in Table 2. In 2015, a majority of the US population with diabetes were
male (53.8%), under the age of 65 (59.6%), non-Hispanic white (58.9%) and were married or a
member of an unmarried couple (61.7%). A majority of the population reported at least some
education at the college level (51.0%). 37.5% had an annual household income over $50,000.
Over 93% of the population with diabetes reported having some form of health insurance
coverage in 2015. Only 33% reported using insulin and more than 58% reported receipt of
formal diabetes education.
Among those who received the ADFSE in 2015, 54.1% were male and 58.2% were under
the age of 65. When race was examined, those who received the ADFSE were 60.5% nonHispanic white, 16.7% non-Hispanic blacks, 14.8% Hispanic and 8.0% of other reported races.
Of those who received the ADFSE 47.9% had less than high school level or had graduated high
school while 52.1% had at least some college education, 48.4% earned less than $35,000 in
annual household income, and 93.9% had some form of health insurance. A majority of people
who received the ADFSE were married or a member of an unmarried couple (61.7%), 17.1%
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Table 4-2- Demographic characteristics of persons aged ≥18 years with diagnosed diabetes, 38 states*
(n=20,882)
Population
Received annual diabetes foot
P value‡
Bivariate
estimate
screening exam in past 12 months
analysis
Yes
No
Odds ratio
%
SE
(95% CI)
78.18±0.93%†
21.82±0.93%†
%
SE
%
SE
DEMOGRAPHIC CHARACTERISTICS
Sex
Male
53.8
1.0
54.1
1.3
53.0
2.5
0.6991
Ref
Female
46.2
1.0
45.9
1.3
47.0
2.5
1.04 (0.84-1.30)
Age (years)
18-64
59.6
1.0
58.2
1.1
64.8
2.2
0.0095
Ref
≥65
40.4
1.0
41.8
1.1
35.2
2.2
0.76 (0.61-0.93)
Race
Non-Hispanic white
58.9
1.1
60.5
1.0
53.5
2.2
0.0012
Ref
Non-Hispanic black
15.8
0.7
16.7
1.0
12.9
2.2
0.88 (0.67-1.15)
Hispanic
16.9
1.0
14.8
1.0
24.2
2.2
1.85 (1.32-2.60)
Other
8.3
0.9
8.0
1.0
9.4
2.2
1.33 (0.76-2.33)
Education
Less than high school
18.8
1.0
17.9
1.0
21.9
2.4
0.2316
1.36 (0.95-1.94)
High school graduate
30.2
0.9
30.0
1.0
30.7
2.2
1.14 (0.87-1.49)
Some college
31.3
1.0
31.9
1.1
29.2
2.3
1.01 (0.76-1.35)
College graduate
19.7
0.8
20.2
0.9
18.2
1.6
Ref
Marital status
Married/couple
61.7
0.9
61.7
1.0
61.8
2.2
0.8703
Ref
Divorced/separated
17.1
0.6
17.1
0.6
17.4
1.4
1.02 (0.81-1.29)
Widowed
11.7
0.5
11.9
0.5
10.9
0.9
0.91 (0.72-1.16)
Never married
9.4
0.5
9.3
0.5
9.0
1.4
1.06 (0.76-1.49)
Annual household income
<$15,000
15.5
0.8
15.3
0.9
16.3
1.9
0.2939
1.21 (0.86-1.68)
$15,000-<$25,000
22.2
0.9
21.5
0.9
25.0
2.4
1.32 (0.97-1.79)
$25,000-<$35,000
11.8
0.6
11.6
0.7
12.6
1.5
1.23 (0.89-1.71)
$35,000-<$50,000
13.0
0.5
13.2
0.6
12.1
1.2
1.03 (0.78-1.37)
≥$50,000
37.5
1.0
38.4
1.1
34.0
2.4
Ref
Health insurance
Yes
93.4
0.6
93.9
0.7
92.4
1.4
0.3018
Ref
No
6.4
0.6
6.1
0.7
7.6
1.4
1.27 (0.81-2.00)
Use insulin
Yes
32.6
0.9
35.7
1.0
21.6
1.8
<0.0001
Ref
No
67.4
0.9
64.3
1.0
78.4
1.8
2.02 (1.60-2.54)
Received diabetes
education
Yes
58.3
1.0
61.3
1.1
47.6
2.5
<0.0001
Ref
No
41.7
1.0
38.7
1.1
52.4
2.5
1.74 (1.40-2.16)
* In 2015, the 38 states that participated in the Diabetes Optional Module included: Arizona, California, Colorado,
Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky,
Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New
Mexico, New York, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas,
Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming. † Percentage of population ± SE. ‡ P-values from χ2
test.
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were divorced or separated from a spouse, 11.9% were widowed and 9.3% were never married.
Finally, among those who received the ADFSE, 35.7% used insulin, 64.3% did not use insulin,
61.3% received formal diabetes education and 38.7% did not receive formal education.
Examining those who did not receive the ADFSE, 53.0% were male and64.8% were
under the age of 65. Among those who did not receive the ADFSE, 53.5% were non-Hispanic
white, 12.9% were non-Hispanic black, 24.2% were Hispanic and 9.4% were of other reported
races. A majority of people who received the ADFSE received at least some college level
education (52.1%) and were married or a member of an unmarried couple (61.8%). Of those
who received the ADFSE, 53.9% had less than $35,000 in annual household income but 92.4%
had health insurance. Finally, among patients who did not receive the ADFSE, 21.6% used
insulin and 47.6% had received formal diabetes education. There were no statistically significant
differences in the receipt of the ADFSE based on sex, education level, marital status, annual
household income or health insurance status.
Table 3 describes the comorbid conditions reported by person over the age of 18 with
diagnosed diabetes. The reports indicate the US population with diabetes have an average of 4.8
comorbid conditions of which 2.9 are considered to be concordant and 1.9 are discordant for the
purposes of this study. Being overweight or obese is the most commonly reported comorbidity
(86.8%) while renal disease is the least commonly reported comorbid condition (8.3%). The
proportion of the population with the remaining concordant comorbid conditions are: 64.4%
have hypercholesterolemia, 13.3% reported a prior MI, 14.1% have CAD, 8.2% report a prior
CVA, and 19.3% report retinopathy. For the discordant comorbid conditions, the population
reports 11.1% currently have asthma, 12.8% have COPD, 20.0% report a history of cancer,
46.3% report an orthopedic condition and 23.3% report depression.
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Table 4-3- Reported comorbid conditions in persons aged ≥18 years with diagnosed diabetes, 38 states*
(n=20,882)
Received diabetes foot screening exam in
P value†
Population estimate
past 12 months
Yes
No
78.18±0.93%†
21.82±0.93%†
%
SE
%
SE
%
SE
CONCORDANT COMORBID CONDITIONS
Hypertension
Yes
71.0
1.0
72.2
1.1
66.5
2.7
0.0396
No
29.0
1.0
27.8
1.1
33.5
2.7
Hypercholesterolemia
Yes
64.4
1.1
64.6
1.1
63.6
2.6
0.7414
No
35.6
1.1
35.4
1.1
36.4
2.6
Prior myocardial infarction
Yes
13.3
0.6
13.8
0.6
11.6
1.2
0.1155
No
86.7
0.6
86.2
0.6
88.4
1.2
Coronary artery disease
Yes
14.1
0.7
15.0
0.8
10.8
1.1
0.0036
No
85.9
0.7
85.0
0.8
89.2
1.1
Prior cerebrovascular
accident
8.2
0.6
8.1
0.6
8.6
1.3
0.7238
Yes
91.8
0.6
91.9
0.6
91.4
1.3
No
Retinopathy
Yes
19.3
0.8
20.5
0.9
15.1
1.5
0.0040
No
80.7
0.8
79.5
0.9
84.6
1.5
Renal disease
Yes
8.3
0.4
8.9
0.5
6.3
1.0
0.0455
No
91.7
0.4
91.1
0.5
93.7
1.0
Overweight/obese
Yes
86.8
0.6
86.8
0.7
86.8
1.4
0.9984
No
13.2
0.6
13.2
0.7
13.2
1.4
DISCORDANT COMORBID CONDITIONS
Current asthma
Yes
11.1
0.5
11.4
0.6
9.9
1.2
0.2753
No
88.9
0.5
88.6
0.6
90.1
1.2
Chronic obstructive
pulmonary diseases
Yes
12.8
0.7
13.5
0.8
10.2
0.9
0.0068
No
87.2
0.7
86.5
0.8
89.8
0.9
Any cancer history
Yes
20.0
0.8
19.4
0.8
22.5
2.1
0.1499
No
80.0
0.8
80.6
0.8
77.5
2.1
Orthopedic issues
Yes
46.3
1.0
46.3
1.1
46.4
2.4
0.9712
No
53.8
1.0
53.7
1.1
53.6
2.4
Depression
Yes
23.3
0.8
22.9
0.9
24.7
1.9
0.3726
No
76.7
0.8
77.1
0.9
75.3
1.9
Population mean
Mean
SE

Received diabetes foot screening exam in
past 12 months
Yes
No
Mean
SE
Mean
SE
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P value‡

Total comorbid conditions
Total concordant conditions
Total discordant conditions

4.77
2.85
1.91

0.04
0.03
0.02

4.80
2.90
1.01

0.04
0.03
0.02

4.63
2.70
1.94

0.10
0.07
0.05

<0.0001
<0.0001
<0.0001

Looking specifically at the population who received the ADFSE, they have an average of
4.8 comorbid conditions with 2.9 concordant and 1.0 discordant condition. Overweight or obese
status (86.8%) remains the most common comorbid condition and renal disease (8.9%) remains
the least common comorbid condition reported. The remaining concordant medical conditions
are reported at rates of: 64.6% for hypercholesterolemia, 13.8% reported having a prior MI,
15.0% report CAD, 8.1% report prior CVA, and 20.5% reported retinopathy. Among the
discordant medical conditions, those who received the ADFSE reported rates of: 11.4% for
having current asthma, 13.5% report having COPD, 19.4% report a history of cancer, 46.3%
have an orthopedic condition and 22.9% report depression.
Among those that did not receive the ADFSE, the study population reported an average
of 4.6 comorbid conditions of which an average of 2.7 are concordant conditions and an average
of 1.9 are discordant conditions. The proportions of concordant comorbid conditions of the
study population who did not receive the ADFSE are: 66.5% with hypertension, 63.6% have
hypercholesterolemia, 11.6% report a prior MI, 10.8% have CAD, 8.6% report a prior CVA,
15.1% have retinopathy, 6.3% have renal disease and 86.% are overweight or obese. Discordant
comorbid conditions are reported at rates of 9.9% with current asthma, 10.2% with COPD,
22.5% have a history of cancer, 46.4% report an orthopedic condition and 24.7% have
depression and did not receive the ADFSE.
The final CFA model demonstrated a good fit between the proposed model and the
observed data based on an RMSEA of 0.011 (90%CI: 0.009-0.013) and a CFI of 0.959.
Standardized and unstandardized parameter estimates are presented in Table 4. The proportion
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of the latent factor variance explained by each indicator is also included in Table 4. None of the
indicators for concordant comorbidities had a variance greater than 37% explained by the latent
factor. For discordant comorbidities, only COPD (59.3%) had over half of its variance explained
by the latent factor. This indicates poor convergent validity between the indicators and latent
factors.
Table 4-4- Unstandardized coefficients, standardized coefficients and percentage of variance explained for
the final CFA model.
Indicator
Latent variable
Unstandardized
Standardized
Percentage of
coefficient (B)
coefficient (β)
variance explained
Hypertension
Concordant
1.00
0.59±0.04
34.8
Hypercholesterolemia Concordant
0.73±0.08
0.43±0.04
18.5
Myocardial infarction Concordant
0.88±0.09
0.52±0.04
27.0
Coronary artery
Concordant
1.06±0.09
0.62±0.03
38.4
disease
Prior cerebrovascular
Concordant
0.87±0.08
0.51±0.03
26.0
accident
Renal disease
Concordant
0.87±0.08
0.51±0.03
26.0
Retinopathy
Concordant
0.59±0.07
0.34±0.04
11.6
Current asthma
Discordant
1.00
0.57±0.04
32.5
Chronic obstructive
Discordant
-1.35±0.15
-0.77±0.06
59.3
pulmonary diseases
Orthopedic disease
Discordant
-1.05±0.08
-0.60±0.03
36.0
Depression
Discordant
-0.97±0.07
-0.55±0.03
30.3

The final SEM model, presented in Figure 1, demonstrated a good fit between with the
observed date. The model fit statistics were: χ2=(df=93)=645.238, p<0.0001, RMSEA=0.017
(90%CI: and CFI=0.807. Given a low CFI value the null model RMSEA was examined and
found to be 0.0346. The low null model RMSEA (<0.158) indicates the CFI is not informative
for this model (113). Table 4 presents the unstandardized probit estimates (β), SEs, and pvalues for regression pathways of the final SEM model. After controlling for age, race, insulin
use and receipt of formal diabetes education the direct effects of concordant comorbidities
(β=0.226, p=0.086) and discordant comorbidities (β=0.080, p=0.415) on the performance of the
ADFSE were not significant. Thus, neither concordant nor discordant comorbidities significantly
contribute to the probability that the ADFSE is performed.
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Figure 4-1- Final SEM model. RMSEA=0.017, null model RMSEA=0.035.

Solid pathways indicate statistically significant model pathways. Dashed pathways indicate non-significant
pathways. HTN – hypertension. HCL-hypercholesterolemia. MI- myocardial infarction. CAD-coronary artery
disease. CVA-cerebrovascular accident. Renal- renal disease. COPD- chronic obstructive pulmonary disease.
Ortho-orthopedic conditions. ADFSE- annual diabetes foot screening exam.
Table 4-5- Unstandardized estimates (β), standard error (SE) and p-values for regression pathways of the
final SEM model.
Unstandardized
Pathway
SE
P-value
coefficient (β)
Concordant comorbidities →
0.23
0.13
0.09
ADFSE
Discordant comorbidities →
0.08
0.10
0.42
ADFSE
Race → ADFSE
-0.09
0.04
0.02
Age → ADFSE
0.154
0.06
0.02
Insulin use → ADFSE
0.35
0.07
<0.0001
Diabetes education → ADFSE
0.27
0.6
<0.0001

CONCLUSIONS
The current findings of this study indicate that there are no simultaneous, direct
associations between concordant nor discordant medical comorbidities and the performance of
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the ADFSE. These results may suggest that the competing demands of chronic comorbid
conditions in diabetes care have little influence on the decision of a health care provider to
perform the ADFSE. Our results are similar to two international studies which also demonstrated
no association between concordant and discordant conditions and the performance of the ADFSE
(72, 73).
However, our results differ from US studies conducted in the mid-2000s through 2011.
While the ADFSE was not included in the studies, researchers found that increasing numbers of
total comorbidities and concordant comorbidities improved performance of some diabetes
quality care processes while discordant conditions reduced performance of at least one care
process (52, 54, 68). To understand the difference between these results and those of these prior
US studies, one must consider the full conceptual model of Piette and Kerr, including the role of
healthcare organizations the management of patients with diabetes (50). Healthcare
organizations place controls on clinical care, such as clinical practice guidelines and
reimbursement strategies that directly influence how health care providers prioritize care in the
clinical environment. In 1995, the ADA, the Centers for Medicare and Medicaid Services
(CMS) and the National Committee on Quality Assurance introduced the Diabetes Quality
Improvement Program (DQIP) which included eight process and outcomes measures (114). The
DQIP program was adopted by CMS, the Veterans Health Administration (VHA) and other
commercial health plans and some progress was made toward improving diabetes quality of care.
The studies which found associations between concordant and discordant conditions and diabetes
quality of care were conducted while the DQIP was being utilized (52, 54, 68). Our study,
utilized data that was collected after the initiation of the CMS Physicians Quality Reporting
Initiative (PQRI) was begun in 2009. The PQRI program was introduced to improve overall
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quality of care in the US and began the transition from fee-for-service to a pay-for-performance
reimbursement model in the CMS patient populations (115). Health care providers are
financially incentivized, through a reward and penalty system, for addressing pre-defined quality
care measures, including the ADFSE for patients with diabetes (106). These financial incentives
for the Medicare and Medicaid populations, may explain the null findings of this study which
were based on data collected in 2015. Given the null findings included people with insurance
other than Medicare and Medicaid, our results may be a reflection of a shift in clinical practice
toward preventive care.
Another possible explanation for our null findings was the use of dichotomous indicators
for the comorbidities. While the CFA model demonstrated a good fit with the data, there was
poor convergent validity between the indicators and the latent factors defined in this study. The
use of dichotomous variables limits the ability to define the severity and level of control of a
disease. Disease severity, level of control and patient symptoms may influence the performance
of screening exams, such as the ADFSE, during clinic visits and should thus be considered in
research (108). Future research using clinical measures of severity and disease control, such as
blood pressure measurements rather than a dichotomous indicator for presence of hypertension,
may help increase convergent validity and thus improve final model fit. However, the issue of
convergent validity may also be an indication that our proposed latent variables of concordant
and discordant comorbidities are not a good statistical representation of the concept of
comorbidity interrelatedness. A 2018 study by Magnan, et al. utilized exploratory factor analysis
to stratify patients by clusters of chronic conditions (116). All five of the clusters explored
increased the odds that diabetes preventive care processes were performed. However, the
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ADFSE was not included. This and other statistical models will need to be explored in future
research.
Despite these potential issues with the statistical model, our study has many notable
strengths. First, it is the first study to utilize a large, nationally representative sample to explore
the simultaneous relationship between types of comorbidities and the performance of the
ADFSE. Second, the use of SEM methods allows for the assessment of the simultaneous effects
of comorbidities that are concordant and discordant with diabetes care, while accounting for
demographic and other characteristics. This is an improvement from prior studies that used
statistical models that could only address count or category of comorbidity. Health care
providers rarely have the luxury to consider each comorbidity in isolation and thus models which
address only count or individual comorbidities are not an ideal representation of the clinical
decision making process. Our model introduced, to a degree, the comorbidity interrelatedness
that health care providers must consider in all clinical decision making processes (108).
While the use of a large, national data set was a strength of this study, the use of the
BRFSS and the cross-sectional study design have additional limitations. First, the BRFSS is
based on self-report and this may introduce recall, misclassification and social desirability bias
into the results. The BRFSS also does not differentiate between individuals with type 1 diabetes
and type 2 diabetes. Given the differences in disease etiology, medical management strategies
and comorbidity profiles for these two populations, it would be prudent to explore the
populations separately, but this is not possible with BRFSS (4). In addition, the BRFSS does not
contain measures of severity for diabetes nor for the other comorbidities explored in this study.
Both Piette and Kerr and Zulman, et al. suggested disease severity be included in the
understanding of diabetes management (50, 108). Conditions that are controlled, or require
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minimal management, may not influence the performance of the ADFSE and result in
overestimation of the contribution of a comorbidity. However, if a condition is dominant or
severe, such as active cancer or end-stage COPD, the patient and health care provider may opt to
forgo diabetes screenings to focus on the dominant condition. Unfortunately, the 2015 BRFSS
does not contain data on disease severity. This lack of information could result in inaccurate
estimates of the association between comorbidities and the ADFSE.
Given the current and potential future burden of DFUs and LEAs on the US population
with diabetes and the burden on the US healthcare system it is important to understand the
factors that influence the performance of the ADFSE. Our study gives an indication there may
be a shift occurring the US health system where factors other than patient level comorbidities are
influencing the performance of this cost-effective and efficient screening exam for the population
with diabetes. The Piette and Kerr conceptual model includes the influence of healthcare
organizations as well as health care provider’s resources and priorities in care. It will be
important to explore all of these factors simultaneously with patient level factors and priorities in
future research on the ADFSE and other diabetes preventive care processes. It is predicted that
more than 64 million Americans will have diabetes in 2050 and up to 34%, or 21 million people,
will have a DFU during their lifetime (3, 23). Given the high cost of care and impact on patient
quality of life, DFUs and LEAs must be reduced in the US population with diabetes.
Identification of influential factors and development of interventions to increase the rate of the
ADFSE to 100% in the US may be the only way to reduce the rates of DFUs and LEAs in the US
and the world.
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CHAPTER 5: The Associations Between Visit Frequency and Competing Demands on the
Performance of the Recommended Annual Clinical Diabetic Foot Screening
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ABSTRACT
Objective: This study to examine the relationship between the performance of other diabetes
preventive care processes, the number of office visits for diabetes care and the completion of the
annual diabetes foot screening exam (ADFSE).
Research Design and Methods: We used the BRFSS data from 38 states (n=19,056) to conduct a
cross-sectional study. Respondents who provided a valid response regarding receipt of the
ADFSE and had at least one visit to a health care provider in the past 12 months were included.
Structural equation modeling was used to assess the simultaneous, direct effects of the
performance of other diabetes preventive care processes and the number of office visits for
diabetes care on the completion of the ADFSE.
Results: In 2015, 80.4% of the US population received the ADFSE. On average, patients with
diabetes received 3.9 diabetes preventive care processes. The collection of preventive care
processes demonstrated a 7% (OR: 1.07, 95%CI: 1.05-1.10) increase in the likelihood the
ADFSE was performed for each unit increase in processes performed. The number of visits to a
healthcare provider for diabetes care was found to have a non-significant association with the
ADFSE (OR=1.00, 95%CI=1.00-1.00, p=0.56).
Conclusions: The completion of increasing numbers of diabetes preventive care processes are
positively associated with the performance of the ADFSE. This may be due, in part, to the recent
implementation of electronic medical records and financial incentives to healthcare providers to
improve overall quality of care in the US healthcare system. Further, research should continue to
explore other approaches which may positively influence the completion of the ADFSE and help
reduce the development of DFUs in the US population.
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INTRODUCTION
More than one-third of the cost of care for patients with diabetes, over $38 billion, in the
US is a result of management of DFUs (117). The cost of managing a patient an active DFU is
estimated to be $28,000-$31,000 annually, nearly twice as much as those who have diabetes
alone (15). When a DFU fails to heal, the ultimate consequence for a patient is LEA. Between
2007 and 2010, up to 5% of patients with diabetes underwent an LEA to resolve a non-healing
DFU (15). Despite medical advances in wound care, the 5-year mortality rate for patients with a
DFU or a LEA is between 45% and 72% (28, 86). However, cost effective ADFSE and patient
education prevention programs can prevent up 75% of DFUs and 85% of LEAs (31, 32).
Despite the benefits of performing the ADFSE, less than three-quarters of the US population
with diabetes received this life-saving screening exam in 2015 (88).
The ADFSE is one of 11 recommended preventive care processes endorsed by the ADA
and CMS which should be performed at least annually for patients with diabetes (114). Between
2009 and 2012, 86% of the population with diabetes underwent blood cholesterol testing but
only 50% received the recommended twice annual HgbA1c blood test (118). Historically,
provision rates of these preventive care screening processes remain suboptimal due to competing
demands. These competing demands including such as provider preferences and expertise, visit
length and, patient concerns, financial constraints and comorbidities (74, 77, 101, 102). The
Piette and Kerr conceptual model explores competing demands for diabetes care and presents
“diabetes medical management” as one factor that has direct influence on diabetes care (50).
While research has explored competing demands from concurrent comorbidities, little is known
about the influences of the frequency of outpatient visit for diabetes care and other diabetes
preventive care processes on the performance of the ADFSE (52, 54, 55, 71) .
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Prior research has demonstrated two to four health care visits per year increased the
likelihood that diabetes preventive care processes, such as HgbA1c testing and retinal exams,
were completed (41, 65, 76, 80). That same frequency of visits to a health provider increased the
odds the ADFSE was performed (41, 65, 76). A 2005 study demonstrated that performance of
mammograms and Pap smears increased significantly as the number of completed diabetes care
processes increased (79). To date, no studies have addressed the influence of both the patient
visits frequency and clinical competing demands on the performance of the ADFSE. Thus, this
study aims to examine the relationship between the performance of other diabetes preventive
care processes, the number of office visits for diabetes care and the completion of the ADFSE.

RESEARCH DESIGN AND METHODS
Data Source and Sample
This study used data from the 2015 BRFSS, an annual, cross-sectional survey conducted
by the CDC (81). The BRFSS surveys non-institutionalized US residents, over the age of 18
years, to collect information on preventive health care practices, health risk behaviors, chronic
diseases, injuries and preventable infectious diseases that affect the US adult population. The
methods for sample weighting to account for the complex sample design are described elsewhere
(82).
In 2015, 38 states participated in the BRFSS Diabetes Optional Module which contained
10 questions specific to diabetes specific self-management activities and recommended
preventive care processes. Survey respondents who answered “yes” to the question “Has a
doctor, nurse or other health professional every told you that you have diabetes?” were included
in the sample eligible to participate in the Diabetes Optional Module (n=36,085). Respondents
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with “pre-diabetes,” “borderline diabetes,” and “gestational diabetes” were excluded from
participation in the Diabetes Optional Module.
Inclusion in this study also required respondents to have at least one foot, at least one
visit to a health care provider for diabetes care in the past 12 months and provide valid responses
to all outcome, exposure and confounder variables. Respondents with no feet (n=328) were
identified by the answer of “no feet” to the survey question “About how often do you check your
feet for any sores or irritations?” Having at least one visit to a health provider for diabetes care
in the past year was determined utilizing the question “About how many times in the past 12
months have you seen a doctor, nurse or other health professional for your diabetes?”
Respondents reporting no visits, “don’t know/not sure” and those who refused to answer the
question were excluded from the study sample (n=4,121). Finally, an additional 12,580
respondents were excluded from the study sample due to invalid responses to the outcome,
exposure and confounding variables. The final study sample size was 19,056.

Measures
The primary outcome of this study was defined as having at least one ADFSE in the past
12 months. The 2015 BRFSS Diabetes Optional Module asks “About how many times in the
past 12 months has a health professional checked your feet for any sores or irritations?”
Responses were continuous between 1 and 76, “none,” “don’t know,” or refused to answer. The
responses were dichotomized to “yes, at least one time” or “no.” Respondents providing answers
of “don’t know” or those who refused to answer were be considered “missing” and excluded
from the data analysis.
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This study’s main exposure variables included the number of visits to a health care
provider for diabetes care and a latent variable to represent the competing demands of diabetes
preventive care processes. The 2015 BRFSS collected information on five of the recommended
processes which included: HgbA1c and cholesterol blood tests, retinal exams, and receipt of
influenza and pneumonia vaccinations. The number of visits for diabetes care was
operationalized using the questions “About how many times in the past 12 months have you seen
a doctor, nurse or other health professional for your diabetes?” Responses were reported as a
continuous number of visits for diabetes care (1-76 visits) or no visits and were retained as a
continuous variable in the statistical model.
The five preventive care processes were defined based on frequency recommendations by
the ADA (4, 33, 119, 120). Responses to the question “About how many times in the past 12
months has a doctor, nurse, or other health professional checked you for “A one C”?” were
dichotomized to “at least 2 HgbA1c tests per year” and “less than 2 HgbA1c tests per year.” The
2015 BRFSS asks respondents “Have you EVER had your blood cholesterol checked?”
Participants who respond “no” were classified as “not adherent to cholesterol screening
guidelines.” For those who answered “yes” to this questions, the follow-up question “About how
long has it been since you last had your blood cholesterol checked?” was asked. Respondents
answering “in the last year” and “in the last 2 years” were categorized as “yes, adherent to
cholesterol screening guidelines.” Those who responded “in the last 5 years” or “5 or more years
ago” were categorized at “not adherent to cholesterol screening guidelines.” Adherence to the
recommendation for comprehensive eye exams was determined by the question “When was the
last time you had an eye exam in which the pupils were dilated?” Responses of “in the past
month,” “in the past year,” and “in the past 2 years” were dichotomized to “yes, adherent with
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recommended retinal exams.” Respondents indicating “2 or more years ago” and “never” were
dichotomized to “no, not adherent with recommended retinal exams.” Receipt of an annual
influenza and pneumococcal vaccinations, were determined by the question “During the past 12
months, have you had either a flu shot or a flu vaccine that was sprayed in your nose?” and
“Have you ever had a pneumonia shot?” The BRFSS collected “yes” and “no” responses and no
recoding was required.
Potential confounders for this study were based on prior studies and included: gender
(male or female), respondent age (<65 year or ≥65 years), race (White non-Hispanic, Black nonHispanic, Hispanic, or other), education (did not graduate from high school, graduated from high
school , attended college or technical school, or graduated from college or technical school),
marital status (married, divorced, widowed or never married), annual household income
(<$15,000, $15,000- <$25,000, $25,000- <$35,000, $35,000- <$50,000, or ≥$50,000), insurance
status (insured or uninsured), insulin use (yes or no) and receipt of a diabetes education course
(yes or no) (65, 68, 77, 79, 80, 101, 121, 122).

Statistical Analysis
Descriptive statistics for all outcome, exposure and potential confounder variables were
calculated with adjustment for the complex sample design of the BRFSS to provide population
level proportions. Descriptive statistics were also provided for the sample stratified by receipt or
non-receipt of the ADFSE. Chi-squared and student’s t-test were utilized to compare groups.
The SEM two step approach was used to assess the simultaneous, direct effects of the
latent variables for competing demands and the number of health care visits have on the
performance of the ADFSE. CFA was conducted to determine the goodness-of-fit for the
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measurement model for the latent variable. The latent variable indicators were: HgbA1c and
cholesterol blood tests, retinal exams, and receipt of influenza and pneumonia vaccinations.
Good model fit was defined by an RMSEA less than 0.05 and CFI of greater than 0.95 (113).
Standardized solutions were calculated for factor loading estimates. Indicators with poor
correlations (r<0.2) to the latent construct were be removed from the model. Model fit was be
reassessed for any trimmed model. Unstandardized and standardized solutions were calculated
for each indicator along with variance explained.
Potential confounding variables were determined by calculating the odds ratio and 95%
CI between each potential confounder and the outcome. The final model included confounders
that had a significant (p<0.05) bivariate association with the outcome. The final structural
model, including the latent variable, number of visits for diabetes care and significant
confounders, was assessed for goodness-of-fit. An RMSEA of less than 0.05 and a CFI greater
than 0.95 . Data analyses were conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC,
USA) and MPlus version 9 (Muthén & Muthén, Los Angeles, CA, USA).

RESULTS
Table 1 presents the descriptive statistics for the total population and stratified based on
receipt of the ADFSE. In 2015, 80.4% of the US population received the ADFSE. The sample
was 51.0% male, 57.4% under the age of 65 and 62.7% non-Hispanic white. A majority of the
population reported having at least some college education (54.0%), were married or in a
member of an unmarried couple (62.5%) and reported an annual household income over $35,000
(52.5%). Over 95% of the population had some form of health insurance, only 34.5% reported
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Table 5-1- Demographic characteristics of persons aged ≥18 years with diagnosed diabetes, 38 states*
(n=19,056)
Population
Received annual diabetic foot
P value‡
Bivariate
estimate
screening exam in Past 12 months
analysis
Yes
No
Odds ratio
%
SE
(95% CI)
80.4±0.9%†
19.6±0.9%†
%
SE
%
SE
DEMOGRAPHIC CHARACTERISTICS
Sex
Male
51.0
1.1
51.6
1.2
51.6
2.4
0.2357
1.14 (0.92-1.41)
Female
49.0
1.1
48.4
1.2
48.4
2.4
Age (years)
18-64
57.4
1.0
56.9
1.2
61.7
2.4
0.0763
0.82 (0.66-1.02)
≥65
42.2
1.0
43.1
1.2
38.3
2.4
Race
Non-Hispanic white
62.7
1.2
63.2
1.3
60.3
2.7
0.0029
ref
Non-Hispanic black
15.0
0.7
16.1
0.8
10.6
1.2
0.69 (0.53-0.90)
Hispanic
14.3
1.0
12.8
1.1
20.4
2.9
1.67 (1.11-2.50)
Other
8.0
1.0
7.8
1.1
8.6
1.7
1.16 (0.69-1.94)
Education
Less than high school
16.0
0.9
16.0
1.0
16.0
2.2
0.7040
0.94 (0.63-1.41)
High school graduate
30.3
0.9
30.0
1.0
31.7
2.3
1.00 (0.75-1.33)
Some college
32.9
1.0
33.2
1.1
30.1
2.0
0.86 (0.66-1.12)
College graduate
21.1
0.9
20.8
1.0
22.1
1.9
ref
Marital status
Married/couple
62.5
0.9
62.7
1.0
61.4
2.2
0.7042
ref
Divorced/separated
16.5
0.6
16.1
0.6
18.0
1.5
1.14 (0.89-1.46)
Widowed
12.2
0.5
12.2
0.6
11.9
1.1
1.00 (0.78-1.27)
Never married
8.9
0.5
8.9
0.6
8.7
1.1
0.99 (0.72-1.37)
Annual Household
Income
<$15,000
14.2
0.8
13.8
0.9
16.0
2.2
0.4751
1.30 (0.89-1.89)
$15,000-<$25,000
21.3
0.8
21.3
0.9
21.2
2.1
1.11 (0.83-1.49)
$25,000-<$35,000
12.1
0.6
11.7
0.7
13.5
1.7
1.29 (0.92-1.80)
$35,000-<$50,000
13.7
0.6
13.7
0.6
13.7
1.4
1.11 (0.84-1.48)
≥$50,000
38.8
1.1
39.6
2.2
35.5
2.2
ref
Health insurance
Yes
95.1
0.5
95.3
0.6
94.1
1.0
0.2613
ref
No
4.9
0.5
4.7
0.6
5.9
1.0
1.28 (0.83-2.00)
Use insulin
Yes
34.5
1.0
37.2
1.1
23.3
2.0
<0.0001
ref
No
65.5
1.0
62.8
1.1
76.7
2.0
1.95 (1.54-2.48)
Received diabetes
mellitus education
Yes
60.3
1.0
63.0
1.1
48.9
2.4
<0.0001
ref
No
39.7
1.0
37.0
1.1
51.1
2.4
1.78 (1.44-2.21)
* The 38 states include: In 2015, the 38 states that participated in the Diabetes Mellitus Optional Module included:
Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois,
Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New
Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South
Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming. † Percentage of
population ± SE. ‡ P-values from χ2 test.
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using insulin for management of diabetes, and 60.3% report having received formal diabetes
mellitus education.
Examining the study population who received the ADFSE in 2015, 51.6% were male and
56.9% were under the age of 65. Race was distributed as follows: 63.2% non-Hispanic white,
16.1% non-Hispanic black, 12.8% Hispanic and 7.8% reported other races. A majority of the
population who received the ADFSE had at least some college level education (54.0%), were
married or a member of an unmarried couple (62.7%) and reported over $35,000 in annual
household income (53.5%). Ninety-five and half percent (95.5%) reported having some form of
health insurance, 37.2% used insulin and 63.0% received formal diabetes education and also
received the ADFSE in 2015.
Among the population that did not receive the ADFSE, 51.6% were male, 61.7% were
under the age of 65. Exploration of the distribution of race in those who did not receive the
ADFSE 60.3% were non-Hispanic white, 10.6% were non-Hispanic black, 20.4% were Hispanic
and 8.6% reported another race. Similar to the population that received the ADFSE, of those
who were not 52.2% were married or a member of an unmarried couple, 49.2% reported an
annual household income over $35,000 and 94.1% reported having health insurance. However,
only 23.3% who used insulin and 48.9% who received formal diabetes education did not receive
the ADFSE.
Table 2 displays the proportion of the total population, and the population stratified by
ADFSE receipt in 2015, who reported completion of the 5 diabetes preventive care processes.
On average, the population received 3.9 of the preventive care practices and had an average of
4.0 visits to a health care provider for diabetes care in the past 12 months. In the population
overall, 81.4% received at least 2 HgbA1c tests in the past 12 months and 98.4% received a
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cholesterol blood test in the past 2 years. Comprehensive visions exams were completed by
88.7% of the study population in the past 12 months. Vaccine receipt was not completed at
similar rates of the other preventive care processes. In 2015, 59.5% received an influenza
vaccine in the past 12 months and 64.4% have ever received the pneumococcal vaccine.
Table 5-2- Reported completion of diabetes preventive care processes in persons aged ≥18 years with
diagnosed diabetes, 38 states* (n=19,056)
Population estimate
Received annual diabetes foot screening
P value†
exam in past 12 months
%
SE
Yes
No
80.4±0.9%†
19.6±0.9%†
%
SE
%
SE
At least 2 HgbA1c tests in
past 12 months
<0.0001
Yes
81.4
0.8
83.4
0.9
73.0
1.9
No
18.6
0.8
16.6
0.9
27.0
1.9
Cholesterol blood test in
past 2 years
Yes
98.4
0.4
98.5
0.5
97.9
0.5
0.3336
No
1.6
0.4
1.5
0.5
2.1
0.5
Comprehensive vision exam
in last 12 months
Yes
88.7
0.6
90.9
0.6
80.0
1.9
<0.0001
No
11.3
0.6
9.1
0.6
20.0
1.9
Received influenza vaccine
in past 12 months
Yes
59.5
1.1
60.6
1.2
54.9
2.4
0.0314
No
40.5
1.1
39.5
1.2
45.1
2.4
Ever receive pneumococcal
vaccine
Yes
64.4
1.1
67.2
1.2
52.9
2.4
<0.0001
No
35.6
1.1
32.8
1.2
47.1
2.4
Population Mean
Mean
SE

Received annual diabetes foot screening
exam in past 12 months
Yes
No

P value‡

Mean
SE
Mean
SE
Visits for diabetes care
3.95
0.13
4.09
0.15
3.41
0.15
<0.0001
Number of diabetes
preventive care processes
3.92
0.01
4.01
0.03
3.59
0.05
<0.0001
completed
* The 38 states include: In 2015, the 38 states that participated in the Diabetes Mellitus Optional Module
included: Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii,
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska,
Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Pennsylvania,
Rhode Island, South Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming.
† Percentage of population ± SE. ‡ P-values from χ2 test.
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When the population was stratified, the group who received the ADFSE receive an
average of 4.0 diabetes preventive care processes and reported an average of 4.1 visit to a
healthcare provider for diabetes care. Of this population, 83.4% received the recommend
number of HgbA1c tests, 98.5% received a cholesterol blood test in the last 2 years and 90.9%
received a comprehensive vision exam in the past year. Finally, 60.6% received the influenza
vaccine in the past 12 months and 67.2% have receipted a pneumococcal vaccine as well are
receiving the ADFSE in 2015.
The population who did not receive the ADFSE reported receiving an average of 3.6
diabetes preventive care processes and attended an average of 3.4 visits to a healthcare provider
for diabetes care. This group reported receipt of diabetes care processes as: 73.0% had 2
HgbA1c tests in the past 12 months, 97.9% have had a cholesterol blood test in the past 2 years,
80.0% have had a comprehensive vision exam in the last 12 months, 54.9% reported receipt of
the influenza vaccine in the past 12 months and 52.9% have received the pneumococcal vaccine.
The fit statistics for the CFA model were: χ2 (df=5)=18.133, p=0.0028, RMSEA=0.01
(90%CI: 0.006-0.018), CFI=0.95. The RMSEA and CFI statistics indicate the measurement
model is a good fit of the data.

Table 3 presents the unstandardized coefficients, standardized

coefficients and the percentage of variance the latent variable explains for each indicator. The
latent variable for competing demands explains over 56% of the variance for the indicator for
receipt of a comprehensive vision exam in the past 2 years. However, the latent variable only
explains 21% of the variance for the indicator for receipt of 2 HgbA1c blood tests in the past 12
months.
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Table 5-3- Final CFA model unstandardized coefficients, standardized coefficients and percentage of
variance explained for each indicator. RMSEA=0.01. CFI=0.95
Indicator
Latent variable
Unstandardized
Standardized
Percentage of
coefficient (B)
coefficient (β)
variance explained
for the indicator
At least 2 HgbA1c
Competing
tests in past 12
1.00
0.46±0.04
21.2%
demands
months
Cholesterol blood test Competing
1.42±0.26
0.65±0.12
42.3%
in past 2 years
demands
Comprehensive
Competing
vision exam in last 12
0.75±0.14
0.34±0.05
56.3%
demands
months
Received influenza
Competing
vaccine in past 12
1.08±0.14
0.49±0.05
24.0%
demands
months
Ever receive
Competing
pneumococcal
1.51±0.18
0.69±0.05
47.6%
demands
vaccine

Figure 1 presents the results of the full SEM model including odds ratios (OR), 95%CI
and p values for each of the paths. The full SEM model fit statistics were: χ2 (df=21)=268.654,
p<0.0001, RMSEA=0.018 (90%CI: 0.016-0.021), CFI=0.832. The null model RMSEA was
found to be 0.038 and indicates the CFI may not be ideal to measure the fit of this model (113).
There was a significant association (P<0.001) between the competing demands latent variable
and performance of the ADFSE. For every unit increase in competing demands, there was a 7%
(OR: 1.07, 95%CI: 1.05-1.10, p<0.0001) increase in the likelihood the ADFSE was performed.
No significant association was present between the number of visits for diabetes care and the
performance of the ADFSE (OR=1.00, 95%CI=1.00-1.00, p=0.56).
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Figure 5-1- Final SEM model. RMSEA=0.036.

Solid pathways indicate statistically significant model pathways. Dashed pathways indicate non-significant
pathways. ADFSE- annual diabetes foot screening exam. Flu- influenza. PNA- pneumococcal.
Table 5-4- Odds ratios (OR), 95% confidence intervals (95% CI)) and p-values for regression pathways of
the final SEM model.
Pathway
OR
95% CI
P-value
Competing demands → ADFSE
1.07
1.05-1.10
<0.0001
Number of visits to healthcare
1.00
1.00-1.00
0.56
provider → ADFSE
Race → ADFSE
0.98
0.97-0.99
0.16
Insulin use → ADFSE
1.07
1.05-1.09
<0.0001
Diabetes education → ADFSE
1.07
1.05-1.09
<0.0001

CONCLUSIONS
The results of this study found that over 80% of patients with diabetes who had at least
one visit to a health care provider received the ADFSE. This rate is exceeds the goal of Healthy
People 2020, but our rate does not include those without a visit to a health provider, and may
help contribute to lower rates of DFUs and LEAs in the future (91). We also found a positive
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association between the performance of an increasing number of other diabetes preventive care
process, often defined as improved quality of care, and the performance of the ADFSE. Our
results suggest that completion of multiple preventive care processes recommended for patients
with diabetes is not competing with the performance of the ADFSE but rather improves
performance of the ADFSE. Unlike prior research, our study did not find a significant
association between the number of visits to a health care provider for diabetes care and the
performance of the ADFSE.
Recent changes in the payments systems in and the structure of the US healthcare
systems may help explain our finding of the positive association between improved diabetes
quality of care and the performance of the ADFSE. Incentive programs by CMS to implement
meaningful use of electronic medical records (EMR), including development of chronic disease
registries, began in the US in 2011 (123). Since that time research has demonstrated that the use
of a diabetes registry in clinical practice improved rates of completion of diabetes preventive
care processes and reduced hospital utilization in this patient population. A systematic literature
review found that the utilization of clinical decision support systems within EMR also
demonstrated improvements in the quality of care provided to patients with diabetes (124). CMS
has also provided 1.5% Medicare payment bonuses to providers who participated in the
Physician Quality Reporting System (PQRS) from 2007 through 2015 (125). The PQRS system
included a Diabetes Measure which included addressing HgbA1c control, influenza vaccine,
vision exams, management of nephropathy, exam for PN and smoking cessation interventions at
specified intervals of patient visits (106). Participation in the PQRS system was associated with
improvements in the provision of the ADFSE along with other quality of care measures in
patients with diabetes (126). The use of inventive payments to improve diabetes quality of care
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is one likely explanation for our positive finding between the performance of diabetes preventive
care processes and the performance of the ADFSE.
The introduction of patient centered medical home (PCMH) model into the US healthcare
system may also explain the positive association between completion of increasing numbers of
diabetes preventive care processes and the performance of the ADFSE (127). PCMHs strive to
provide accessible, patient-centered, coordinated and comprehensive clinical care. Data
collected by the MEPS, a nationally representative survey, revealed patients who belong to a
PCMH had higher rates of completion of ADA recommended diabetes preventive care processes
compared to those patient who did not belong to a PCMH (118). The VHA has also
implemented the PCMH model and demonstrated improvements diabetes quality of care (128).
Specifically, the ADFSE completion rates have increased. In 2013, nearly 20% of US primary
providers reporting belonging to a PCMH model (129).
This study has many strengths including being the first study, to our knowledge, to
explore the simultaneous association between competing demands of diabetes care and the
number of visits for diabetes care. Our study also utilized a large, national data set which
provided results that are generalizable to the US population with diabetes. In addition, the
BRFSS is also used to inform Healthy People 2020 which increases the external validity of our
results (62). The main outcome of our study, self-report of the ADFSE, has been validated in
prior studies, which reduces the risk of misclassification bias in our results (43, 103).
Despite these strengths, our study has several limitations. The self-report nature of the
BRFSS data may introduce recall and social desirability bias into our results while the cross
sectional design limited determination of causality. Another major limitation is the inability to
differentiate patients with type 1 diabetes and type 2 diabetes in the study sample. Given the
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differences in disease management, prioritization of preventive care processes, and the
management of other comorbidities, the joint analysis of both populations may cancel out a
difference in effect (4). In addition, the BRFSS does not have information on the number of
visits respondents make to other health care providers for management of medical issues other
than diabetes. Diabetes specific preventive care processes may have been completed in these
visits but not accounted for in our analysis.
In conclusion our study sought to explore the relationship between competing demands
and the number of visits for diabetes care and the performance of the ADFSE. Improving overall
diabetes quality of care can potentially improve the rates of ADFSE completion. Thus programs
to aid health care providers in completion of diabetes preventive care processes, such as use of
EMR, financial incentives to complete preventive screenings and the PCMH model, should be
further explored to determine their effect on increasing the rates of the ADFSE and ultimately,
the reduction of DFUs and LEAs. While the benefit of ADFSE on the prevention of these life
threatening complications are well known, efforts must be made to increase their application in
the US clinical care environment. Reports from 2017 estimate that between 1.0 million to 3.5
million people in the US have had a DFU at some point in their lifetime and more than 100,000
underwent an LEA (8, 23). These numbers can only be reduced with provision of evidencebased screening and prevention practices.
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CHAPTER 6: Summary
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SUMMARY
DFUs and LEAs continue to be a major public health problem and result in decreased
quality of life for patients and high costs of care for the US healthcare system (8, 15, 24, 130).
Rates of DFUs and LEAs can be reduced through comprehensive screening and prevention
programs (32, 33). The ADA and the IWGDF recommend patients with diabetes receive a
comprehensive diabetic foot exam at least once a year (33-35). However, population estimates
from 2012 demonstrated that only 71% of the US population received the ADFSE (38). Clinical
reports of completion of the ADFSE vary from 12% to 95% (39-46). Prior research has
identified age, race, gender, education, insurance and rural residency are factors that are
associated with the performance of the ADFSE (47-49). However, little research has explored
the association between clinically meaningful factors and the performance of the ADFSE. The
aim of this dissertation was to examine the associations between clinically meaningful factors
and the performance of the ADFSE. The Piette and Kerr conceptual framework on competing
demands of chronic comorbid conditions in diabetes care was utilized to guide the analyses (50).
Our studies found between 78.2% and 80.4% of patient with diabetes, who had at least one visit
to a healthcare provider for diabetes care, received the ADFSE in 2015.
Chapter 3, titled “Are diabetes mellitus self-management behaviors associated with the
receipt of the recommended annual diabetes foot screening examination?” examined the
relationship between 8 individual diabetes self-management behaviors and the performance of
the ADFSE. The eight diabetes self-management behaviors included: performing SMBG at least
one time per day, performing a self-foot inspection at least one time per day, receipt of the
influenza vaccine in the past 12 months, receipt of the pneumococcal vaccine at any time,
meeting aerobic and resistance training exercise recommendations, smoking status and alcohol
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consumption. Logistic regression models were used to assess the association between an
individual self-management behavior and the receipt of the ADFSE. One-way interactions with
insulin use status and receipt of formal diabetes education were also examined to determine if
these variables modified the association between a self-management behavior and performance
of the ADFSE. Insulin use was found to modify the association between receipt of the influenza
vaccine, performance of the recommended dosage of aerobic exercise and avoidance of
excessive alcohol consumption. However, the receipt of the influenza vaccine and the
performance of the recommended dosage of aerobic exercise did not demonstrate significant
associations with the performance of the ADFSE when the effect modification by insulin use was
considered. Among those who do not use insulin and do consume an excessive amount of
alcohol there is more than 3 times increased odds ADFSE is performed compared to those who
do not use insulin and avoid excessive alcohol usage. Both status of insulin use and of the
receipt of formal diabetes education were found to be significant effect modifiers of the
relationship between performance of SMBG at least one time per day and the receipt of the
ADFSE. Among the groups who do not use insulin and did and did not receive formal diabetes
education, those who do not perform SMBG at least one time per day were over 48% less likely
to receive the ADFSE compared to counterparts who did perform the recommended selfmanagement behavior. These results suggest that patient education programs which educate
patients on and encourage performance of self-management behaviors may help improve the
rates of performance of the ADFSE in the US population with diabetes.
Chapter 4, entitled “The association between comorbidities and the performance of the
recommended annual diabetic foot screening examination” examined the simultaneous, direct
effects of concordant and discordant comorbidities on the performance of the ADFSE. SEM
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methods were employed to simulate clinical decision making which allows for consideration of
multiple types of information to be considered in parallel. No significant simultaneous, direct
associations between concordant nor discordant medical comorbidities and the performance of
the ADFSE were found. These results may indicate that decisions about performance of the
ADFSE are not influenced by patients’ comorbidity profiles. They may also be a reflection of
changing payment models and quality reporting requirements which been implemented over the
past decade within the US healthcare system.
The last chapter, Chapter 5, titled “The associations between visit frequency and
competing demands on the performance of recommended annual clinical diabetic foot screening”
examined the associations between the performance of other diabetes preventive care processes,
the number of office visits for diabetes care and the completion of the ADFSE. SEM method
were utilized to explore these associations simultaneously. The number of visits to a healthcare
provider for diabetes care was found to have a non-significant association with the ADFSE in
our model. The model demonstrated a positive association between the performance of an
increasing number of other diabetes preventive care process, often defined as improved quality
of care, and the performance of the ADFSE. Our results suggest that completion of multiple
preventive care processes recommended for patients with diabetes is not competing with the
performance of the ADFSE but rather improves performance of the ADFSE. These results
suggest that programs which encourage healthcare providers to improve overall quality of care to
patients with diabetes may be one way to improve the performance of the ADFSE.
Implementation of patient programs to increase patient activation and participation in their own
care, and empowering patients to request providers perform all recommended preventive care,
may also help improve the performance of the ADFSE.
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IMPLICATIONS FOR PUBLIC HEALTH
Diabetes is predicted to affect more than one-quart of the US population by 2050 (3).
By this time, as many as 44 million US residents will develop a DFU in their lifetime (3, 23,
131). Given the poor quality of life and high cost of care with a DFU, immediate action is
needed to reduce the rates of DFUs and LEAs in those with diabetes (15, 130, 132). While
recent population level intervention to improve overall diabetes care in the US have made
headway, further work is required to ensure the problems of the diabetic foot are also addressed
(133).
First, public awareness of the complication of the diabetic foot, DFUs and LEAs needs to
increase in the US. While November is “National Diabetes Awareness Month”, The Save a Leg,
Save a Life Foundation began the “White Sock Campaign” in 2013 (134, 135). The “White
Sock Campaign” was designed to raise awareness of the complications of diabetes and PAD. At
this time the campaign needs to extend beyond the walls of medical buildings and into the public
domain to increase awareness of patients, family members, and caregivers of those with diabetes.
National education programs, such as those successfully used in research studies, designed to
increase patient and caregiver awareness of the diabetes foot and provide strategies to help
reduce the risk of DFUs are also necessary to empower the population to combat this growing
public health problem (31, 32).
Second, all healthcare providers should be trained and encouraged to administer the
ADFSE during every patient interaction, or at regular intervals during periods of care. The exam
can be performed by a variety of healthcare providers such as physician podiatrists, nurses,
physical therapists and pharmacists (37). The exam requires less than 5 minutes to complete and
is low cost, requiring only a 3.06 Semmes-Weinstein monofilament. With more healthcare
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providers performing the ADFSE, more patients at risk for DFU development can be identified
and referred to appropriate prevention and treatment programs. However, the number of these
programs remains suboptimal in the US, and internationally, due to lack of time in the clinical
setting, inconsistent healthcare provider training and reimbursement concerns (136). Policy
makers and health insurance providers will need to make DFU prevention a priority and
implement changes to support healthcare providers and provide patients with evidence based
care.

FUTURE RESEARCH
Future research is necessary to ensure that 100% of the US population with diabetes
receives the ADFSE. While this dissertation found positive associations between the ADFSE
and various clinically relevant factors, the cross-sectional nature of the data precludes the ability
to determine causality. Longitudinal data, from EMRs, national registries or prospective studies,
will be required to explore whether diabetes self-management behavior and performance of other
diabetes preventive care processes lead directly to improved rates of performance of the ADFSE.
Additional studies on these topics will also benefit from exploring T1DM and T2DM
populations separately and provider type (eg- general practice vs. endocrinology). Given the
differences in disease etiology, age of onset differences, and differences in health care service
utilization it will be important for future studies to ensure each patient group receives appropriate
research consideration (4, 137). Prior research has also identified provider type can influence the
performance of preventive health services (77, 100-102, 137). Specific to diabetes preventive
care, endocrinologists were more likely to administer HgbA1c test and retinal exams compared
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to primary care physicians (100). Prioritization of the multiple recommended diabetes
preventive care processes also differs by provider type (77).
Exploration of the effect modification by status of insulin use and diabetes education is
also required in future research. It is possible that some portion of the effect modification by
insulin use, found in this dissertation, may be due to the differences in the management of T1DM
and T2DM mentioned previously (4). These effect modifications may also be explained by other
physiologic measures, such as HgbA1c level, blood cholesterol levels or blood pressure that are
used to determine relative control of diabetes and associated comorbidities (120). The effect
modification based on receipt of diabetes education which was observed in this dissertation
should also be further explored. One prior study has demonstrated that while diabetes education
and knowledge improve patient performance of self-management behaviors, it does not have an
association with completion of preventive care nor control of metabolic measures (94). It is
possible that diabetes education is a proxy for a yet unexplored variable that may explain group
differences. Finally, while not explored in this dissertation, future research will also need to
determine if effect modification by status of insulin use or formal diabetes education, exists
when other pathways of the Piette and Kerr model are examined (50).
Ultimately, future research will also need to firmly establish if the positive findings of
this dissertation will reduce the rates of DFUs and LEAs in the US. DFU and LEA rate
reductions have resulted from comprehensive programs that began with the ADFSE and then
provided appropriate interventions and follow up (31, 32, 138-142). Margolis, et al. utilized the
BRFSS and demonstrated a negative association between receipt of colorectal cancer screening
and LEAs suggesting that receipt of preventive care processes may reduce LEAs (92). However,
this study did not find any significant associations between the examined diabetes self-
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management behaviors, some of which were explored in this study, and LEAs. Regardless, a
causal link must be established between diabetes self-management behaviors and the
performance of other diabetes preventive care processes, the ADFSE and reduction in rates of
DFUs and LEAs to ensure early interventions at the prevention level will result in a positive
outcomes on quality of life for patients with diabetes and reduce the burden on the healthcare
system.
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Association- Combined Sections Meeting. Febuary 21-24, 2018. New Orleans, LA.
Sando, TA., Perera, R., Lu, J. The Influence of Comorbid Conditions on the Performance of
Annual Comprehensive Foot Examinations in the US Population with Diabetes
Mellitus. Symposium on Advanced Wound Care. April 5-9, 2017. San Diego, CA.
Sando, TA. Regional Variations in Three Activity Limitations in the US Population. American
Physical Therapy Association- Combined Sections Meeting. February 15-18, 2017. San
Antonio, TX.
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Cohen, SA., Cook, S., Hall, L., Sando, TA. What Aspects of Rural Life Contribute to Ruralurban Health Disparities in Older Adults? Evidence from a National Survey. American Public
Health Association Annual Conference. October 29-November 2, 2016. Denver, CO.
Cohen, SA., Kelley, L., Cook, SK., Sando, TA. Geographic Variability in Rural-Urban
Disparities in Obesity Among Older Adults: Why Place and Policy Matter. AcademyHealth
Annual Research Meeting. June 26-28, 2016. Boston, MA.
Sando, TA.¸ Cohen, SA. Predictive Factors of Daily Self-foot Inspection in the US Population
with Diabetes Mellitus. Symposium on Advanced Wound Care. April 13-17, 2016. Atlanta,
GA.
Sando, TA., Ratliff, S., Cohen, SA. Patient Reports of Post‐CVA Functional Impairments are
the Driving Force Behind Post‐Acute Therapy Referrals. American Physical Therapy
Association- Combined Sections Meeting. February 17-20, 2016. Anaheim, CA.
Sando, TA., Bareis, N., Cohen, SA. Psychiatric Medication Use is Associated with Increased
Impairments in the Vestibular and Proprioception Systems. American Physical Therapy
Association- Combined Sections Meeting. February 17-20, 2016. Anaheim, CA.
Sando, T., Cohen, SA. Predictive Factors of Diabetic Foot Screening Rates in the United
States. American Public Health Association Annual Conference. October 31-November 4,
2015. Chicago, IL.
Sando, T., Cohen, SA. Do functional mobility and activity of daily living deficits after a
cerebrovascular accident influence the referral to physical and occupation therapy? American
Public Health Association Annual Conference. October 31-November 4, 2015. Chicago, IL.
Cook, S., Cohen, SA., Sando, TA., Kelley, L. Demographic and socioeconomic modifiers of the
association between caregiving intensity and caregiver health: Evidence from a national
caregiving survey. American Public Health Association Annual Conference. October 31November 4, 2015. Chicago, IL.
Cohen, SA., Kelley, L., Cook, S., Foutz, J., Sando, TA. Geographic variation in rural-urban
obesity rates in older adults: Evidence from a national survey. American Public Health
Association Annual Conference. October 31-November 4, 2015. Chicago, IL.
Sando, T., Cohen, SA. Diabetic foot screenings: Who are we missing? Symposium on
Advanced Wound Care- Spring 2015. April 29-May 3, 2015. San Antonio, TX.
Cohen, S., Sando, T., Phillips, A., Kelley, L., Sherif, Y., Brown, M. Associations between
caregiving intensity and caregiver burden in "sandwiched" caregivers: Results from the new
National Study of Caregiving. American Public Health Association Annual Conference.
November 15-19, 2014. New Orleans, LA.
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Phillips, A., Cohen, S., Sando, T. Emerging caregiver burden domains in the new National
Study of Caregiving: Results, reliability, and applications. American Public Health Association
Annual Conference. November 15-19, 2014. New Orleans, LA.
Sando, T. Treatment of a Complex Wound Surrounding Infected Total Artificial Heart
Drivelines. Symposium on Advanced Wound Care. September 27-30. Las Vegas, NV.
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